__MAIN_TEXT__

Page 1


Dear Friends, We are proud to share with you our 2015 annual report, which highlights our continued commitment to advancing the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer.

100

percent goes directly to pancreatic cancer research

A Focused Mission and Valued Partnership Our mission is to advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer by: • I ncreasing funding and support of research into the biological mechanisms and clinical strategies related to diagnosis, treatment and prevention • Facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts • Heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for patients, their families, and friends

Awards As a result of our significant awareness-building, fundraising and research initiatives, we are proud to announce that The Lustgarten Foundation has been honored with two noteworthy awards in 2015. These awards reinforce our commitment to raising awareness and funding for pancreatic cancer research and provide us with renewed energy and enthusiasm to help us reach our goal of one day finding a cure for this aggressive disease.

Charity Navigator

Long Island Business News

The Lustgarten Foundation has been recognized for the seventh consecutive year with the highest rating as a four star charity by Charity Navigator, the country’s premier independent charity evaluator – a designation that only 2 percent of the charities rated by this prestigious organization have received. Charity Navigator ratings demonstrate to donors how efficiently they believe a charity will use its support, and to what extent the charity is growing its programs and services over time. The rating also is an invaluable measure of the public’s opinion on how trustworthy, ethical and fiscally responsible a nonprofit is. Please view our profile at www.charitynavigator.org.

The Lustgarten Foundation was honored by Long Island Business News with a Nonprofit of the Year Award, an industry standard for organizations that are dedicated to the economic and social well-being of the Long Island, NY community. Honorees for this prestigious Corporate Citizenship – The Business of Giving Award were selected by a committee of business leaders for their efforts in going above and beyond as outstanding corporate citizens and for their commitment to the greater good.

Cover: The organoid offers the hope of personalized cancer treatments. Organoid image courtesy of Dannielle Engle, Ph.D., The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory

The pancreatic cancer landscape has dramatically changed since The Lustgarten Foundation was founded 18 years ago, and the Foundation has played a leading role in that change. By adopting a focused research strategy, we have concentrated our efforts on working with world-renowned cancer research experts who have applied their knowledge and expertise to charting a new course for pancreatic cancer – a path that will lead to increasing survival rates and finding a cure. We are making substantial progress, in spite of limited government funding for pancreatic cancer research, and we are making it count for the patients who need our help now. In fact, 2015 marked a turning point for The Lustgarten Foundation, as we are on the cusp of exciting scientific breakthroughs from our Lustgarten-funded researchers in areas including immunotherapy and personalized medicine that could alter the course of pancreatic cancer and provide a renewed sense of hope and promise for pancreatic cancer patients and their loved ones. On the pages that follow, we highlight the noteworthy research we have funded with your support. We spotlight the groundbreaking studies being led by our Director of Research and Distinguished Scholar, Dr. David Tuveson, at The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory. Dr. Tuveson and his team are conducting multiple studies with organoids, a reproduction of a human pancreas tumor, which will open new avenues for personalized medicine. Multiple drugs can be tested on a patient’s organoid to see which therapy shows the best response for the patient. This is the beginning of a new way of customizing treatment, offering hope to patients and dramatically improving patient care and prognosis. We also report on the ongoing research conducted by our other Distinguished Scholar award recipients, Dr. Bert Vogelstein, Johns Hopkins University School of Medicine, Dr. Ronald Evans, Salk Institute for Biological Studies, and Dr. Douglas Fearon, Cold Spring Harbor Laboratory and Weill Cornell Medical College. These accomplished researchers and our Research Investigators are conducting studies on early detection, immunotherapy, and potential new treatments that will impact outcomes. Additionally, we highlight our ongoing collaboration with Stand Up To Cancer, which now extends to four pancreatic cancer research teams that are tackling the disease using novel approaches. We want to take this opportunity to express our heartfelt gratitude to our many friends – our generous supporters, volunteers, walk leaders, event sponsors, Board of Directors, and Scientific Advisory Board. As a result of your dedication, we once again reached an all-time fundraising high of more than $20 million in 2015, and we held more than 300 community events and over 30 Pancreatic Cancer Research Walks nationwide. And, due to the support of Cablevision, 100 percent of every dollar donated to The Lustgarten Foundation went directly to pancreatic cancer research. In honor of all of the members of our patient community and their loved ones, we will continue to pursue our mission to accelerate a path towards a cure, and we look forward to updating you on our research and fundraising efforts throughout 2016. Sincerely,

Charles F. Dolan

Robert F. Vizza, Ph.D.

Kerri Kaplan

Chairman

President & Chief Executive Officer

Executive Director & Chief Operating Officer


A Tribute To Cablevision A Vision Fulfilled In 1998, when a young 51-year-old Marc Lustgarten, Cablevision Vice Chairman, was diagnosed with pancreatic cancer, Charles F. Dolan and James L. Dolan, along with Marc, had a vision for a foundation dedicated to curing this difficult disease through research. Our mission remains steadfast — to advance research related to the diagnosis, treatment, cure and prevention of pancreatic cancer while raising public awareness and providing support for patients and their families. At the time The Lustgarten Foundation was established, pancreatic cancer was indeed an “orphan” disease, with less than $16 million, or 0.5 percent of the total National Cancer Institute’s budget supporting less than 15 researchers nationally. The founding fathers provided all the initial financial support to launch The Lustgarten Foundation. In 2008, in response to the leadership of Chairman Charles Dolan and Chief Executive James Dolan, Cablevision committed to pay all of The Lustgarten Foundation’s administrative expenses. This enabled the Foundation to publicly state that, “100% of every dollar donated goes directly to pancreatic cancer research” — a most powerful message. As a result, the impact on fundraising and research expenditures has been dramatic, with fundraising increasing threefold from $6.7 million to nearly $20.5 million in the period from the start of the sponsorship through 2015. Research expenditures increased fivefold from $19 million before Cablevision’s support to a total of $118 million through 2015, making The Lustgarten Foundation the nation’s largest private funder of pancreatic cancer research. In addition to this financial support, Cablevision created and supported our curePC campaign, which significantly raised awareness, provided patient information and helped increase fundraising. As a result, The Lustgarten Foundation’s impact on research has been substantial, supporting many major pancreatic cancer research milestones. Significant initiatives we have undertaken include: conducting research and clinical trials that led to the first new combination therapy in eight years; sequencing the genome; developing a personalized medicine model; developing an early detection blood test; harnessing the body’s own immune system to fight the disease; and developing a deeper understanding of the molecular biology underlying pancreatic cancer.

August 30, 1999: Marc Lustgarten, Vice Chairman of Cablevision and Chairman of Madison Square Garden, dies of pancreatic cancer. (Charles and Jim Dolan establish The Lustgarten Foundation for Pancreatic Cancer Research, which becomes the nation’s largest private funder of research for the deadly disease.)

lity for the me responsibi su as to on t en tion so that all Cablevision w garten Founda rectly to funding st Lu he T of could go di full overhead to the nonprofit tion, which was established contributions da 2015, the foun more than research. As of buted over $110 million to ri st arch centers in 1998, had di ects at 60 medical and rese foundation oj pr at priv e 200 research me the largest er research. co be d ha d an reatic canc worldwide devoted to panc in the country

To chronicle the amazing history and growth of Cablevision and the role played by Charles Dolan and the Dolan family, there is a privately published and fascinating book entitled Charles Dolan and the Cablevision Journey. On the following page are excerpts that describe the beginning of The Lustgarten Foundation.

2 • THE LUSTGARTEN FOUNDATION

, when e spring of 1998 th in ed rr cu oc profound ways ny’s makeup in pa m co e th d . ge that altere ncreatic cancer Another chan nosed with pa ag di as w en rt • Marc Lustga ily. He was the ablevision fam ar, Jim pointed C er rg la e th by arts. In particul ion ans, as well as ted by the Dol nation of book and street sm t the other side in a negotiat ec sp re d an d ve bi ha lo w m e be co in a as w essing Marc to determ ew Yorker, poss arkable ability consummate N ading people, and his rem r re to his knack fo d. te • be a death really wan y accepted to el rg la as w it ; er pancreatic canc r research for fo ey on m tle ere was lit At the time, th • e was no sentence. clear that ther unch e m ca be it n he la Cablevision. W Jim decided to to everyone at tment or cure, Charles and listed their industry g in tt se up ly sis was deep y effective trea Marc. They en join a media advisory Marc’s diagno disease, nor an the outcome for people like e th r fo them—to st te n urdoch among nouncements to spread lp change M he early-detectio t er to up on R ti d da Foun one, an ice an The Lustgarten vin, Barry Diller, John Mal levision-created public serv Le ab d C al er st G ca d to tele friends— bers committe . Charles board; the mem disease and the foundation on’s president. ti da un fo e w th ne the cer Institute, awareness of would become meet with the National Can ho w g , za iz V ob d to Dr. B e fourth-leadin ch facilities an ed for help to , which was th ar rn er se tu nc re s ca so al ic ou s ri at an re va The Dol ctors at for panc izza to visit do finding a cure traveled with V ore money and energy into tm the gravity States. urging it to pu e statistics and in in the United as hs se at di e de th er of nc e re ar cause of ca Dolans were aw e being administered anywhe underway, the in e ic er w ed m on e ti iv da at e or altern for the foun Even as plans sis. If there was a new vaccin h ug no ho lt ag t it. A of Marc’s di sure that he go ors originally e ad m ey th , the world of his doct nger than any ic cancer he survived lo ed of pancreat di en rt ga st Lu c . predicted, Mar at the age of 52 in August 1999

None of this would have been accomplished without the support of Cablevision. It has enabled us to build a solid, leading foundation, and to ensure that The Lustgarten Foundation will continue to flourish going forward. Our five-year plan projects a doubling of our research budget so as to realize the mission envisioned by our founders.

To Charles, James, and all at Cablevision — we are eternally grateful and pledge to complete your vision, our mission — an ultimate CURE for pancreatic cancer, and we thank you for your continued support.

y

vision Journe

able lan and the C o D s le r a h C Excerpts From

ity Music age at Radio C illion, st on an ol D es e venue’s $70 m Jim and Charl 1999 to mark th t also launches The er ob ct O in l Hal even storation. The reatic Cancer Research, seven-month re nc Pa r fo on ti Madison unda Lustgarten Fo levision Vice Chairman and ab named after C hairman Marc Lustgarten. nC de ar G re ua Sq

Marc Lustgarten, photographed by Charles Dolan, on a sailing trip shortly before his death. ANNUAL REPORT • 3


Research

In 2015, The Lustgarten Foundation initiated its OPT (Organoids for Personalized Therapy) trial, the first of its kind using human pancreatic cancer organoids to impact clinical care. This initiative is led by Dr. Tuveson and Project Manager, Herve Tiriac, Ph.D., at The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory (CSHL). In 2014, Dr. Tuveson’s laboratory published findings on the first organoid model for pancreatic cancer in the prestigious journal Cell. Now, the team aims to apply this model to the clinic.

David Tuveson, M.D., Ph.D., Director of The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory, Professor and Deputy Director of the Cancer Center at Cold Spring Harbor Laboratory

The first in a series of organoid-based projects, the primary goal of the OPT study is to demonstrate the effectiveness of the organoids as a precision medicine platform for pancreatic

4 • THE LUSTGARTEN FOUNDATION

The team will then conduct a retrospective trial, in which they will compare the organoid’s responsiveness to the therapies to the patient’s actual clinical experience. In that way, the accuracy of the organoid as a predictor of drug response will be demonstrated. The next phase of the study will be a prospective trial in which the patient’s organoid will be tested prior to treatment to select what could be the most effective treatment for that patient. With a limited treatment window following diagnosis, there is an urgent need to correctly identify effective therapeutic options with the greatest likelihood to help the patient, making the development of the organoid critical. “The organoid represents a significant step forward for the future of cancer treatment,” said Dr. Tuveson. “We are confident that the OPT trial is just the beginning of a new way of customizing treatment at the time of diagnosis, offering hope to patients and dramatically improving the way that pancreatic cancer is managed.” Dr. Tuveson and his team have now made the organoid technology available to the entire pancreatic cancer research community through an educational course offered at Cold Spring Harbor Laboratory. Nearly 30 researchers have taken this class to date to learn how to create an organoid from a tumor in order to develop a personalized approach to treating patients. Our ultimate goal, therefore, is to make the first adaptable personalized medicine approach to treating pancreatic cancer, in the hopes of increasing survival rates substantially.

Joseph Kellard

cancer patients. To accomplish this goal, CSHL researchers will first collect 100 tumor tissues, from both patients who have undergone surgery and from the biopsies of metastatic patients, from several approved clinical sites throughout the country. The organoids will undergo a comprehensive evaluation, including genetic sequencing and therapeutic screening. Based on this evaluation, researchers will be able to characterize the patient’s organoid by its mutations and its responsiveness to over 120 FDA-approved chemotherapeutic and targeted therapies.

Joseph Kellard

Presently, it is difficult to determine how a patient will respond to a particular treatment, and therefore, the patient becomes the subject for testing. In the laboratory, the organoid becomes the subject for testing. The long-term goals of the organoid research project are to provide new, focused treatment options for patients based on their tumor’s genetic mutations. In this research project, the patient’s tumor organoid is genetically sequenced, and its genetic makeup is characterized. It is then “treated” with many compounds and combinations of compounds to determine which are the most effective in killing the cancer cells. This process — sequencing and screening drugs — is the essence of personalized medicine, where the precise treatment for each individual patient is selected based on the genetic makeup of the individual tumor. To date, a handful of patients have volunteered to have organoids developed for research purposes, and the preliminary results have been encouraging. In one case, a patient’s organoid did not respond to the current standard of care, and this result correlated to the patient’s actual response to those treatments. The organoid did respond well to a different therapy, and as a result, the patient was switched to that therapy.

Joseph Kellard

– David Tuveson, M.D., Ph.D.

The Lustgarten Foundation’s dedicated Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory is concentrating much of its research on the highly innovative field of personalized cancer treatment, marking a new era in the way we customize treatment. At the heart of our research program, David Tuveson, M.D., Ph.D., The Lustgarten Foundation’s Director of Research, and his team are focused on creating a personalized medicine platform using their recently developed “organoid,” which is a reproduction of a human tumor that offers hope to patients for dramatically improving their care and prognosis. An organoid can be reproduced indefinitely in the laboratory and then available drugs can be tested to determine

which one(s) have the best response for a particular patient.

Joseph Kellard

“The organoid represents a significant step forward for the future of cancer treatment. We are confident that the OPT trial is just the beginning of a new way of customizing treatment at the time of diagnosis...”

New Directions In Treatment Using Organoids For Personalized Medicine

Joseph Kellard

Interest in, and support for, pancreatic cancer research has grown substantially in recent years, as more scientists and clinicians are choosing to focus on this severely underfunded disease. Today, there are more than 1,000 researchers actively working to find a cure for pancreatic cancer, and there are nearly 750 pancreatic cancer clinical trials currently taking place across the country. The Lustgarten Foundation has significantly contributed to the growth of pancreatic cancer research by supporting more than 200 projects at more than 60 institutions worldwide. At the end of 2015, The Lustgarten Foundation’s commitment to pancreatic cancer research totaled more than $118 million since inception. In order to have the greatest impact on this disease, The Lustgarten Foundation has adopted a Focused Research Strategy — with emphasis on earlier detection, personalized therapy for individual patients and translational research to increase treatment options, which are highlighted in the research section that follows.

Researchers at The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory conduct innovative research to identify new treatments for pancreatic cancer. ANNUAL REPORT • 5


The Lustgarten Foundation Expands Collaboration With Stand Up To Cancer (SU2C) The Lustgarten Foundation is pleased to recognize its long-term collaboration with Stand Up To Cancer (SU2C) which now extends to three pancreatic cancer Dream Teams and one pancreatic cancer research team engaging world-renowned scientists, with all projects involving clinical trials, leading to patient benefits in the three-year funding cycle. To date, The Lustgarten Foundation has committed more than $14.5 million to this collaboration for Stand Up To Cancer’s four pancreatic cancer research teams. We believe strongly that combining our resources and best practices with SU2C strengthens our research program and will move us more quickly towards significant progress.

SU2C brings together the best and brightest minds to accelerate research so that new therapies can get to patients quickly and potentially save lives. The first pancreatic cancer Dream Team was one of the five inaugural 2009 SU2C Dream Teams funded from the first SU2C telecast in 2008. Led by Daniel D. Von Hoff, M.D., TGen, and Craig

Ted Buchanan, Med Meeting Images

– Dr. Elizabeth M. Jaffee, Johns Hopkins University School of Medicine

Dream Team Program

Robert H. Vonderheide, M.D., D. Phil, University of Pennsylvania, and Elizabeth M. Jaffee, M.D., Johns Hopkins University School of Medicine

6 • THE LUSTGARTEN FOUNDATION

Additionally, the Dream Team developed a new imaging method to scan patients for tumors, based on the presence of glutamine, which provides the energy that the cancer cells need to grow and survive. The Dream Team’s research also demonstrated that early detection of recurrent pancreatic cancer was possible by testing blood samples for tumor DNA, called a “liquid biopsy.” Researchers determined that the blood tests were a more accurate way to learn if the disease had recurred following surgical removal of the tumor compared to standard-of-care imaging approaches. In fact, with the liquid biopsy, return of the disease was identified 6.5 months sooner than through imaging approaches. The SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team: Transforming Pancreatic Cancer to a Treatable Disease, initiated in 2014 in conjunction with the Fox Family Cancer Research Funding Trust, aims to develop new therapies using patients’ own immune cells to treat their cancers through the five trials it is currently conducting. The team is also conducting studies to develop combination treatment approaches and biomarkers. It brings together leading individuals in the fields of immunotherapy, genetics, informatics, biostatistics, regulatory/clinical trials, cancer

biology and pathology from nine institutions. Elizabeth M. Jaffee, M.D., Johns Hopkins University School of Medicine and Robert H. Vonderheide, M.D., D.Phil., University of Pennsylvania are, respectively, Leader and Co-leader of the project. In November 2015, the Stand Up To Cancer (SU2C) – Cancer Research UK – Lustgarten Foundation Dream Team: Reprogramming of Transcriptional Circuitry to Control Pancreatic Cancer, comprised of leading researchers from the United States and the United Kingdom, was announced at the AACR Molecular Targets meeting. This third Dream Team, led by Daniel D. Von Hoff, M.D., TGen, and co-led by Ronald M. Evans, Ph.D., Salk Institute for Biological Studies, and Gerard I. Evan, Ph.D., University of Cambridge, focuses on reprogramming pancreatic cancer cells so that they become less aggressive and more sensitive to drugs and anti-cancer immune responses. Through this research, the Dream Team’s goal is to improve the survival rate of pancreatic cancer patients, at least doubling the one-year survival in advanced pancreatic cancer patients from 35 percent to more than 70 percent, and to maintain remission in patients who have responded to treatment. A pancreatic cancer translational research team was formed under the direction of Jeffrey A. Drebin, M.D., Ph.D., University of Pennsylvania, to explore the effects of synthetic Vitamin D on the immune cells that enter the pancreatic cancer tumor. Dr. Drebin’s team will conduct a clinical trial of Gemcitabine, Abraxane and synthetic Vitamin D, followed by treatment with an immunotherapy drug that is currently FDA-approved for certain types of melanoma and lung cancer.

Stand Up To Cancer Scientific Summit Researchers from these four pancreatic cancer

Ted Buchanan, Med Meeting Images

“We are confident that our research will result in significant advances in identifying new immunotherapy treatments.”

Thompson, M.D., Memorial Sloan Kettering Cancer Center, the team initiated clinical trials to test new drug combinations. Their research resulted in the discovery of combining Abraxane with Gemcitabine, which became the first new drug combination therapy approved for pancreatic cancer in eight years (since Tarceva was FDA-approved for use with Gemcitabine in 2005), as well as a standard of care for patients with metastatic cancer of the pancreas. Their research demonstrated that Abraxane combined with Gemcitabine increased one-year survival by 59 percent as compared to Gemcitabine alone.

From left to right: Ronald M. Evans, Ph.D., Salk Institute for Biological Studies; Daniel D. Von Hoff, M.D., TGen; Jeffrey A. Drebin, M.D., Ph.D., University of Pennsylvania; and Gerard I. Evan, Ph.D., University of Cambridge teams recently convened at the Stand Up To Cancer Annual Scientific Summit in California, where they had the opportunity to share ideas and best practices and provide feedback and suggestions for further research. This summit is particularly valuable in allowing researchers to share data, collaborate and achieve the best value in their research to potentially change the lives of thousands of patients and their families.

A Look Ahead Our pancreatic cancer Dream Teams have already made significant strides in our understanding and treatment of the disease. The cancer landscape is changing rapidly, and The Lustgarten Foundation, in collaboration with SU2C, believes we are on the verge of discovering additional new, advanced therapies that could be life-saving.

“Thanks to the support of Stand Up To Cancer and The Lustgarten Foundation, patients and their families should be more hopeful about quantity and quality of life than ever before.” - Dr. Daniel D. Von Hoff, TGen

ANNUAL REPORT • 7


Distinguished Scholars Apply Novel Approaches To Early Detection And Treatment

–B  ert Vogelstein, M.D.

Bert Vogelstein, M.D., Johns Hopkins University School of Medicine, is continuing to expand his research on a DNA-detecting blood test for pancreatic cancer to a larger, more diverse population. The goal of this research is to have a reliable blood test that can be administered at a doctor’s office during a routine appointment. Dr. Vogelstein is also studying the importance of surveillance in monitoring pancreatic cysts. In a successful study funded by The Lustgarten Foundation, Anne Marie Lennon, M.D., Ph.D., and her colleagues at Johns Hopkins University School of Medicine, led by Dr. Vogelstein, have identified a panel of molecular markers and clinical features that show promise for classifying pancreatic cysts and determining which cysts are likely to become malignant and require surgery, and which cysts are likely to remain benign and require monitoring only. This important finding was published in the November 2015 issue of the esteemed journal Gastroenterology. This more specific panel of markers will provide physicians with additional information to help them decide

8 • THE LUSTGARTEN FOUNDATION

Focusing on more effective treatment for patients, Dr. Bert Vogelstein and his colleagues, Dr. Luis Diaz and Dr. Dung Le, recently published promising results in The New England Journal of Medicine using an immunotherapy drug called Pembrolizumab. Results demonstrated that cancer patients whose tumors had a unique mutation called “microsatellite instability” (MSI) responded to Pembrolizumab, even when other forms of therapy were not effective. There are potentially 2 percent or more pancreatic cancer patients who are MSI-positive and have the opportunity to potentially benefit from treatment with Pembrolizumab, which is not yet FDA approved for the treatment of MSI pancreatic cancer. As a result of the initial results with Pembrolizumab, The Lustgarten Foundation has launched a public awareness campaign to recruit patients and cover the costs to have their tumors tested for MSI so they have the opportunity to enroll in this promising clinical trial. Dr. Vogelstein also published an article in the American Association for Cancer Research’s journal Cancer Discovery highlighting the largest and most comprehensive genetic analysis of hereditary pancreatic cancer predisposition ever performed. Dr. Vogelstein and his team sequenced the genomes of 638 patients with familial pancreatic cancers and found that there are a number of different genes that explain familial pancreatic cancer, rather than just one gene, and that it is a highly genetically diverse disease.

Ronald Evans, Ph.D., Salk Institute for Biological Studies, is closely investigating the relationship between pancreatic cancer cells and the cells in the stroma, the supportive tissue surrounding the tumor. Dr. Evans believes that the stromal cells send growth signals to the pancreatic cancer cells, and if these signals are blocked, the tumor will stop growing. Dr. Evans and his colleagues are testing how to do this, and are aiming to block the factors that promote the cancer. Thus far, they have discovered that by blocking a specific growth factor with a drug, a major cancer-causing gene is then blocked, and could prevent pancreatic tumor growth. Further research will be done to confirm if this will work in patients. In addition to this research, Dr. Evans continues to investigate the effectiveness of a derivative of Vitamin D in the clinical setting through his collaboration with Brian Wolpin, M.D., M.P.H., Dana-Farber Cancer Institute, and Eileen O’Reilly, M.D., Memorial Sloan Kettering Cancer Center. Drs. Wolpin and O’Reilly are performing standard biopsies on pancreatic cancer tumors. Dr. Evans then analyzes the

Douglas Fearon, M.D., Cold Spring Harbor Laboratory and Weill Cornell Medical College, is conducting research to better understand the immune system’s role in pancreatic cancer. Pancreatic cancer cells can prevent a person’s immune system from attacking it by sending “stop” signals to the immune cells, which allows the cancer to evade cell death and continuously grow. Dr. Fearon’s research is investigating how immunotherapy drugs can turn these “stop” signals into “on” signals that can attack and kill the cancer. He currently has a clinical trial at Weill Cornell Medical College using immunotherapy drugs that sensitize pancreatic cancer cells to immune attack by boosting the

tissue biopsy samples to establish a biomarker profile for patients whose tumors express the Vitamin D receptor. Tumors expressing this receptor are candidates for treatment with paricalcitol, a synthetic Vitamin D drug that targets and shuts down the “stromal cells” that surround the cancer cells and prevents chemotherapy from penetrating the tumor. By shutting down the activity of the stromal cells, the chemotherapy is more effective.

“Pancreatic cancer is an epic challenge to both the patient and the family and the job of the scientist is to offer new weapons to take control of the disease.” – Ronald Evans, Ph.D.

number of cancer-destroying immune cells in the tumor.

Weill Cornell Medical College

“We now understand this disease on the molecular level, at the genetic level, in an unprecedented way. All of the genes that are altered, and the molecular bases for these genetic alterations, are known.”

whether surgery or surveillance is the most appropriate course of action for their patients, based on the type of mutation they see in a particular cyst. Certain cysts often lead to malignancy and need to be surgically removed, and others typically remain benign. More than 800 patients have been recruited from the United States, Europe and the Far East for this research, significantly surpassing the original target of 300 patients, and this research is scheduled for presentation at a major medical conference in 2016.

Salk Institute for Biological Studies

Johns Hopkins Kimmel Cancer Center

The Foundation’s Distinguished Scholars grant recipients are world-class scientists at the top in their field and at the forefront of today’s most exciting breakthroughs in pancreatic cancer research. Selected by The Lustgarten Foundation’s Scientific Advisory Board (SAB), each grantee receives $5 million in funding over five years, enabling them to pursue high-risk, high-reward science to accelerate a path to a cure and conduct research to improve how the disease is detected and treated.

“We’re starting to discover that the immune system can, under certain circumstances, help patients who are given certain new drugs control cancer growth.” – Douglas Fearon, M.D. ANNUAL REPORT • 9


Research Investigators Advance The Study of Pancreatic Cancer The Lustgarten Foundation has funded 13 prominent scientists based at top institutions across the country through our Research Investigator program. Researchers were nominated by either the director of one of the 68 National Cancer Institute (NCI) designated cancer centers nationwide or by members of the Foundation’s Scientific Advisory Board (SAB). Award recipients each receive three-year grants of up to $1.5 million. We invite you to explore what each of our Research Investigators is studying:

“There is absolutely hope in the fight against pancreatic cancer, and early detection is one of our most powerful tools for conquering the disease.” – Alison P. Klein, Ph.D., M.H.S., Johns Hopkins University School of Medicine

Dr. Cantley’s research focuses on how a p53 mutation, the second most commonly mutated gene in pancreatic cancer, affects cell metabolism and cell signaling pathways that promote pancreatic cancer. Channing J. Der, Ph.D. University of North Carolina, Chapel Hill, NC Dr. Der’s study focuses on the proteins that KRas signals to. His research has revealed important findings about what makes a cancer cell sensitive or resistant when targeting the KRas pathway. This will help immensely as we aim to find a drug to target KRas, the mutation found in almost all pancreatic cancer patients. Stephen W. Fesik, Ph.D. Vanderbilt University Medical Center, Nashville, TN Dr. Fesik’s study aims to target other proteins that interact with the mutated KRas protein by using specially designed small molecule inhibitors that he created in hopes of indirectly killing KRas-expressing cancer cells.

Charles S. Fuchs, M.D., M.P.H. and Mandar Muzumdar, M.D. Dana-Farber Cancer Institute and Massachusetts Institute of Technology, Boston, MA This research, being conducted simultaneously in humans and in mouse models, aims at better understanding how obesity and diabetes correlate to pancreatic cancer.

Dr. Leach’s project uses a systematic approach to testing a very large number of different drug combinations in hopes of finding some that work best for certain groups of patients, based on specific biomarkers that would make patients appropriate candidates for particular drugs.

Tony Hunter, Ph.D. Salk Institute for Biological Studies, La Jolla, CA

Scott W. Lowe, Ph.D. Memorial Sloan Kettering Cancer Center, New York, NY

Dr. Hunter’s study aims to more closely examine the relationship between cancer and stromal cells and identify pro-cancerous growth factors in hopes of targeting these factors to starve and kill the pancreatic cancer cells. Dr. Hunter’s research to date has demonstrated that when a specific cancerpromoting signal is blocked, mice with pancreatic cancer are living longer.

Dr. Lowe’s research uses powerful genetic screening tools to identify genes that pancreatic cancer cells depend upon in hopes of more selectively and effectively killing cancer cells. In conjunction with Steven Leach, M.D., Dr. Lowe is using a new model for pancreatic cancer — the “speedy mice” — that develops pancreatic cancer more quickly than the conventional models, allowing for a significant number of drug combinations to be tested in a short time.

Tyler Jacks, Ph.D. Massachusetts Institute of Technology, Cambridge, MA

Dana-Farber Cancer Institute

Dr. Jacks is using new-age genetic screening technology to discover more easily “druggable” gene products that mutant KRas-expressing cells are dependent upon to target, instead of KRas itself. Dr. Jacks will investigate how cancer cells will react if we effectively inhibit mutant KRas.

10 • THE LUSTGARTEN FOUNDATION

Steven D. Leach, M.D. Memorial Sloan Kettering Cancer Center, New York, NY

Alison P. Klein, Ph.D., M.H.S. Johns Hopkins University School of Medicine, Baltimore, MD Dr. Klein is developing and validating models that clinicians can use to identify individuals who are at the highest risk of pancreatic cancer and therefore should be targeted for early detection screening. These risk factors include exposure to cigarette smoke, diabetes, pancreatitis (inflammation of the pancreas) and a family history of pancreatic cancer.

Frank McCormick, Ph.D., F.R.S. RAS Initiative National Advisor, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD University of California, San Francisco, San Francisco, CA Dr. McCormick’s study aims to target the stem cell markers expressed on KRas expressingpancreatic cancer cells in hopes of sensitizing them to chemotherapy and killing them. He has discovered a way to reverse the cancerpromoting signals of KRas. Hidde L. Ploegh, Ph.D. Massachusetts Institute of Technology, Cambridge, MA Dr. Ploegh is developing a novel, non-invasive approach to imaging very small tumors, even smaller than what is detectable with the current standard of imaging.

Stanford University School of Medicine

Lewis C. Cantley, Ph.D. Weill Cornell Medical College, New York, NY

Julien Sage, Ph.D. Stanford University School of Medicine, Stanford, CA Dr. Sage’s research targets a different class of proteins, known as KMTs, which play a role in pancreatic cancer progression. He has found a new cancer-causing protein that is a potential drug target, and he is now testing the effects of some therapies on this new target. Dr. Sage and his team are also focusing their research on combination therapies. If the therapies work together in a synergistic fashion, this could enhance the treatment response and reduce the chance of therapeutic resistance. Diane M. Simeone, M.D. University of Michigan Medical Center, Ann Arbor, MI Dr. Simeone’s study aims to sort and collect circulating tumor cells in a patient’s blood and then grow them in the laboratory for therapeutic testing and genetic sequencing.

“We’ve learned a great deal about the molecular wiring of pancreas cancers, and we’re in a position now to take advantage of that knowledge with new treatment strategies.” – Tyler Jacks, Ph.D., Massachusetts Institute of Technology

ANNUAL REPORT • 11


Cutting-Edge Research Influences Patient Outcomes With an overall survival rate of just 8 percent over five years, we don’t hear often enough about the courageous men and women who are beating these odds and giving a new face to the fight against pancreatic cancer. At this pivotal time in pancreatic cancer research, when we are on the cusp of potential scientific breakthroughs, we highlight below the inspiring stories of four pancreatic cancer patients and survivors who have benefited from Lustgarten-funded research that is having a profound impact on the detection and treatment of this disease.

The Life-Changing Power of Immunotherapy Treatment In 2014, 52-year-old engineer David Blevins was diagnosed with pancreatic cancer that had metastasized to his liver. After a year of grueling chemotherapy treatment so debilitating that he was frequently unable to work, he threw his energy into finding a clinical trial. His research led him to Dr. Dung Le of Johns Hopkins University, and while he didn’t qualify for the initial trial he was hoping to participate in, Dr. Le convinced him to have his tumor tested for a rare MSI mutation (see page 8). On the same day that he was told by one of the many leading medical centers that he visited that there was nothing left to offer him besides chemotherapy, he received the life-changing call from Dr. Le that his tumor tested positive for the mutation. He was the first patient enrolled in a clinical trial for an immunotherapy drug targeting MSI, sponsored by The Lustgarten Foundation. Now, after more than 30 treatments over 14 months, David is doing phenomenally well. He is working again, experiencing minimal, manageable side effects and is fully engaged in his active family life with his wife and four children. At his most recent

The Life-Saving Impact of Early Detection In 1994, retired surgeon Thomas Collins joined the National Familial Pancreas Tumor Registry at Johns Hopkins University, spearheaded by Dr. Ralph Hruban, a Lustgarten-funded researcher who focuses on early detection and familial pancreatic cancer. Tom was deeply concerned after several of his relatives, including his mother, passed away from pancreatic cancer. As part of the Lustgarten-funded CAPS (Cancer of the Pancreas Screening) research study led by Dr. Marcia Canto, a colleague of Dr. Hruban’s at Johns Hopkins University, Tom started making the trip from his home in Maine to Baltimore for an annual endoscopic ultrasound screening. Dr. Canto told him that few people continued coming for a screening for so many years; doing so most likely saved his life. During his eleventh screening in 2013, the ultrasound revealed a lesion the size of a pencil eraser – the smallest pancreatic cancer tumor to date discovered at Johns Hopkins. Tom underwent surgery and then 18 rounds of chemotherapy infusions. 12 • THE LUSTGARTEN FOUNDATION

scan, there was no evidence of any more liver metastases, and his pancreas tumor had shrunk by more than 68 percent. And, because an MSI trial site recently opened at Ohio State University, he no longer needs to travel from his home in Indiana twice every month to Johns Hopkins in Baltimore for his infusions.

Success with the First Pancreatic Cancer Vaccine David Blevins and his wife Carol Photo courtesy of David Blevins

Kathleen Dowell was only 50 years old when she was diagnosed with pancreatic cancer in 1997, after doctors initially mistook her symptoms for gallstones. At first she was in complete shock and disbelief, as very little was even known about pancreatic cancer, and then she feared she would never live to see her newborn grandchild grow up. After undergoing surgery and chemotherapy, Kathleen was approached by Dr. Elizabeth Jaffee’s team at Johns Hopkins University to participate in a small study testing the first adjuvant pancreatic cancer vaccine (GVAX). She recalls her surgeon Dr. Cameron saying to her, “Mrs. Dowell, you could be the one to survive,” and those words were the encouragement she needed to try the vaccine. After just two GVAX doses, she became ineligible to continue due to complications from her prior chemotherapy treatment. However, she had the highest immune response of anyone in the study and now, 18 years later, she is cancer-free and has watched all four of her grandchildren grow up. The Lustgarten Foundation has funded Dr. Jaffee’s ongoing research on the GVAX vaccine.

Kathleen Dowell (4th from left) surrounded by Dr. Dan Laheru (2nd from left), Dr. Elizabeth Jaffee (3rd from left), and the rest of her medical team Photo courtesy of Johns Hopkins University

BRCA Mutation and Pancreatic Cancer Treatment

Now, more than two years after surgery, Tom has been given a second chance on life and runs a cancer support group, sharing his story of hope with other pancreatic cancer patients and their loved ones.

Dr. Ralph Hruban with Tom Collins Photo courtesy of Dr. Hruban

In 2015, Jim Foley, a 71-year-old retired engineer and 15-year prostate cancer survivor from Westchester County, New York, was undergoing genetic testing to determine if he had the BRCA mutation, which two of his daughters and other family members have, when a routine CT scan for his long-term prostate cancer showed that he had a pulmonary embolism and metastatic pancreatic cancer. His entire world was turned upside down, as he learned that the embolism was caused by Stage IV pancreatic cancer that had metastasized to the liver. He was immediately referred to Dr. Eileen O’Reilly at Memorial Sloan Kettering Cancer Center, where he was also being treated for his prostate cancer. He learned that he tested positive for the BRCA mutation, which Dr. O’ Reilly said was actually beneficial because it gave her a roadmap for how to treat his tumor. She also said that BRCA patients often respond very well to standard of care chemotherapy. Now, a year since diagnosis, Jim shows no signs of slowing down. The tumor in his pancreas is not detectable and the lesions in his liver are dramatically reduced; in fact, his CA 19-9 and CEA tumor marker levels are now within the normal range. Jim experiences few side effects on

the standard of care treatment regimen. Jim is busy spending his time with his wife, three daughters, and seven grandchildren. Jim also led Team Foley’s Fighters at the Foundation’s recent Westchester Pancreatic Cancer Research Walk, raising $3,300 for critical research.

Jim Foley walks in Dr. O’Reilly's honor at the Westchester Pancreatic Cancer Research Walk Photo courtesy of Kerri Kaplan

The Lustgarten Foundation is funding two significant initiatives focused on the BRCA mutation. Several patients in a trial funded by The Lustgarten Foundation and led by Dr. Eileen O’Reilly at Memorial Sloan Kettering Cancer Center are having impressive results taking a PARP inhibitor in combination with cisplatin and gemcitabine. According to Dr. O’Reilly, the trial is likely to define a standard treatment approach for people with BRCA mutations. The Lustgarten Foundation is also funding the first comprehensive registry for people with a BRCA mutation, as well as those with a family history of BRCA mutations. This initiative is spearheaded by Dr. David Kelsen at Memorial Sloan Kettering Cancer Center. ANNUAL REPORT • 13


The Lustgarten Foundation and Cablevision Systems Corporation partnered in the curePC campaign, an award-winning public service campaign that raises awareness about pancreatic cancer and the Foundation’s efforts in the battle against this disease.

1 Team. 1 Mission. The curePC campaign’s series of online and print public service announcements (PSAs), “1 Team. 1 Mission.,” highlights how everyone’s contributions matter in the fight to beat pancreatic cancer. The series features the many team members – scientists, physicians, volunteers, caregivers and fundraisers – whose efforts help us make a difference. Pictured left: Dr. Eileen O’Reilly, Memorial Sloan Kettering Cancer Center, and Joseph, a walk participant.

Pancreatic Cancer Awareness Month In recognition of Pancreatic Cancer Awareness Month this past November, the curePC campaign launched a multifaceted online and social media initiative featuring easy ways to raise awareness and join #TeamcurePC. And on November 13, many Foundation supporters, including celebrities and members of the media, joined together for a special social media effort to mark World Pancreatic Cancer Day, reaching more than 12 million followers.

Pictured right: Dr. Dannielle Engle, Cold Spring Harbor Laboratory, and Garrett, a future researcher, fundraiser and student.

#WalkToCurePC The curePC campaign continued to raise awareness of the Foundation’s largest walks, including the Foundation’s flagship walk on Long Island. Held in October, the Long Island Walk welcomed 8,000 participants and raised $1.3 million. For more on the Foundation’s national walk series, see page 18.

Anthony Carrino and John Colaneri, the popular stars of HGTV’s “Kitchen Cousins,” “Cousins on Call” and “America’s Most Desperate Kitchens,” showed their support of the Foundation by appearing in television and print public service announcements for the curePC campaign. The PSAs emphasize the early detection research that the Foundation is funding and the great hope that this potentially life-saving research may offer.

Brian Stanton

New PSAs with HGTV’s “Cousins”

100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

14 • THE LUSTGARTEN FOUNDATION

ANNUAL REPORT • 15


Events

Committee members (l-r) Hope Wolfe, Stacy Remnitz, Shari Dusansky and their daughters.

Partygoers give a thumbs up after testing the track!

On December 16th, Cablevision Systems Corporation, The Madison Square Garden Company, and AMC Networks hosted the 15th annual Holiday Rock & Roll Bash to benefit The Lustgarten Foundation. Held for the first time at the exclusive TAO Downtown in New York City, the Bash attracted over 1,000 people and raised more than $2 million for the second consecutive year, with 100 percent of every dollar raised going directly to support pancreatic cancer research. Since its inception in 2001, the Holiday Rock & Roll Bash has raised $21 million for pancreatic cancer research.

On January 30th, more than 300 guests attended our 3rd annual New York City winter fundraiser, Party with a Purpose, held at the famous Marquee in the West Village. Guests enjoyed creative cuisine, danced to the sounds of DJ Matt Winters, participated in an auction with soughtafter prizes, and were entertained by a strolling magician and a dancing robot. Special thanks to our presenting sponsor Celgene and the dedicated event committee. Party with a Purpose garnered nearly $185,000, bringing the total raised from this event to more than $407,000.

16 • THE LUSTGARTEN FOUNDATION

On February 6, the inaugural Race 4 A Cure took place at Grand Prix New York, an entertainment complex in Westchester County. Led by more than a dozen committee families from the surrounding community who have been impacted by pancreatic cancer, the event’s family-driven format brought together kids, teens and adults in the quest for a cure. With entertainment and music provided by Total Entertainment, indoor go kart racing, bowling, a bounce house and arcade, it was a fun-filled night for all. The fundraiser, emceed by Lisa LaRocca of News 12 Westchester, featured passed hors d’oeuvres from highly acclaimed local restaurants and a dinner and dessert buffet. Attendees also enjoyed a silent auction offering prizes including vacation packages, sports memorabilia, gift cards from top-rated restaurants, and show tickets and entertainment. The fundraiser attracted 400 people and raised more than $140,000 for The Lustgarten Foundation.

We are proud to have worked with many dedicated supporters, patients and friends to increase awareness of pancreatic cancer and raise significant research funding through community events held across the country. We have highlighted some of our long-standing events below, as well as the people who have inspired them.

Kevin Wood

During the program, Andrew and Jessica Lustgarten paid tribute to their late father Marc Lustgarten, who passed away from pancreatic cancer in 1999. They were joined by James Dolan, chief executive of Cablevision and executive chairman of The Madison Square Garden Company, who expressed his deep appreciation to the corporate sponsors whose generous donations to the Bash support the Foundation’s mission to find a cure. James Dolan and Cablevision Chairman Charles Dolan helped establish The Lustgarten Foundation in 1998 in honor of Mr. Lustgarten, who served as the former vice chairman of Cablevision and chairman of Madison Square Garden before he died from pancreatic cancer.

The dancing robot entertains an enthusiastic attendee. Ben Asen

Party with a Purpose

Cathy Burnham

Avi Gerver

Holiday Rock & Roll Bash

Race 4 A Cure

Ben Asen

DJ Questlove, popular drummer of The Roots (house band for The Tonight Show Starring Jimmy Fallon), performs at TAO Downtown to a crowd of more than 1,000 Bash guests.

Ben Asen

The Rockettes give an exclusive Radio City Christmas Spectacular performance at the 15th annual Holiday Rock & Roll Bash to benefit The Lustgarten Foundation.

Avi Gerver

Our community outreach initiatives continued to expand in 2015. With nearly 300 fundraisers and community events, we are propelled forward by the momentum, spirit and dedication of our valued volunteers, corporate sponsors, friends and other supporters who make these events possible and who so significantly contribute to our ability to fund cutting-edge research.

Members of the Ivanoski family gather to honor Eddie at the 2015 golf outing.

Mayor Margot Garant, past commodore Charles Chiaramonte, Ralph Macchio, Maurice DuBois, and commodore John Ciarelli attend the regatta.

Eddie Ivanoski Memorial Golf Tournament

Village Cup Regatta

The golf tournament honors the legacy of Edward “Eddie” Ivanoski, who served with the Marine Corps and as a Boston police officer and detective for 40 years. Eddie passed away from pancreatic cancer — one of five members of his family to die from the ravaging disease that also took the lives of his brother Leonard Ivanoski, two sisters Jean Morris and Irene White and nephew John Morris. The annual golf event, started in 2005, celebrates Eddie’s love for the sport and provides an opportunity for the Ivanoski family and their entire community to join together to raise money for a disease that has taken so much from them. To date, the event has raised nearly $229,000 for The Lustgarten Foundation’s research initiatives.

The Village Cup Regatta was founded in 2010 by the Port Jefferson Yacht Club (formerly the Setauket Yacht Club) located on Long Island, New York as an annual event to raise funds for research related to the treatment and cure of pancreatic cancer. On September 12th, two teams — one comprised of Port Jefferson residents, and one made up of hospital staff — raced 30 boats amidst the cheers of hundreds of spectators. Actor/director Ralph Macchio and Maurice DuBois, who anchors the evening news for New York’s CBS affiliate and who grew up in Port Jefferson, served as the Village Cup Ambassadors. The Village Cup Regatta has raised $304,000 since inception, with funds shared equally between The Lustgarten Foundation and John T. Mather Memorial Hospital’s Palliative Care Program, located in Port Jefferson.

ANNUAL REPORT • 17


2015 Financial Highlights

Walks/Runs The Lustgarten Foundation’s nationwide walk program brings together patients, their families and loved ones, community leaders, corporations and business owners in the fight against pancreatic cancer. The events support The Lustgarten Foundation’s mission of funding research and increase awareness of pancreatic cancer in communities across the country. They also provide the opportunity for all those affected by the disease to gather together in the spirit of hope and to celebrate the promise of research and the potential for a cure.

Cash, Investments and Receivables

$58,047,588

$55,941,964

Outstanding Funds Committed to Research

$40,015,342

$49,112,152

Unrestricted Undesignated Net Assets

$17,315,601

$6,675,360

Research Expenditures

$19,386,821

$14,226,765

Annual Fundraising Revenue

$20,484,436

$19,481,221

Liz Morales

2000-2015 ANNUAL FUNDRAISING REVENUE

David Laake

Ben Asen

$15,000,000

$10,000,000

$5,000,000

Ben Asen

Kevin Kennedy

$0

Thank you to all the walk leaders and volunteers and congratulations to all those who organized and participated in the 2015 events, which surpassed past years in terms of how much funding the walks have raised for research! Albany, NY Bridgewater, NJ Boston, MA Brooklyn, NY Cedar Rapids, IA Chicago, IL Cromwell, CT Denver, CO Dutchess County, NY

2015 2014

$20,000,000

Photo Courtesy of Tara Shanes-Hernandez

–R  ichard D. Goldstein, Long Island walk team leader

$25,000,000

We could not be more grateful to our sponsors, teams, walkers and volunteers who joined us and helped the walk program raise considerably more for research than it did in past years.

“With every mile I walk, and every dollar I raise for The Lustgarten Foundation, I am honoring my brother’s memory.”

DECEMBER 31

The audited financial statements of The Lustgarten Foundation are available on our website or upon request. Ben Asen

In 2015, more than 19,000 people participated in our 31 walks. With events in 14 states, representing every corner of the country, the Pancreatic Cancer Research Walk series raised more than $3.9 million — a 4 percent increase over 2014 — in our quest to find a cure for pancreatic cancer. This brings our walk program total to nearly $31 million, since our first walk was held in 2001 on Long Island, NY.

Fairfield County, CT Fremont, CA Fort Myers, FL Green Valley, AZ Howard County, MD Lehigh Valley, PA Long Island, NY Middlesex, NJ Milford, CT

Monmouth County, NJ Naperville, IL New York City, NY Paramus, NJ Pemberville, OH Pennsauken, NJ San Francisco, CA St. Louis, MO Syracuse, NY

Valley of the Sun, AZ Westborough, MA Westchester, NY Westlake Village, CA

’00

’01

’02

’03

’04

’05

’06

’07

’08

’09

’10

’11

’12

’13

’14

’15

2000-2015 CUMULATIVE RESEARCH GRANTS $120,000,000

$100,000,000

$80,000,000

$60,000,000

$40,000,000

$20,000,000

$0

18 • THE LUSTGARTEN FOUNDATION

’00

’01

’02

’03

’04

’05

’06

’07

’08

’09

’10

’11

’12

’13

’14

’15

ANNUAL REPORT • 19

e lativ


Leadership

Donors

BOARD OF DIRECTORS

CORPORATE ADVISORY BOARD

SCIENTIFIC ADVISORY BOARD

Charles F. Dolan Chairman Cablevision Systems Corporation

The Honorable Jimmy Carter Honorary Chairman

Ronald M. Evans, Ph.D. Salk Institute for Biological Studies

Our important mission could not be accomplished without the assistance of the many generous individuals, foundations, corporations, volunteers and organizations that support us. We wish there was enough space to thank each individual who has ever made a gift, however please know that each gift is deeply appreciated.

Frank A. Bennack Jr. Former Chief Executive Officer Hearst Corporation

Douglas T. Fearon, M.D. Cold Spring Harbor Laboratory & Weill Cornell Medical College

FOUNDERS

Barry Diller Chairman and Senior Executive IAC/InterActiveCorp and Expedia, Inc.

Tyler Jacks, Ph.D. Massachusetts Institute of Technology

William Bell Retired Vice Chairman Cablevision Systems Corporation James L. Dolan Chief Executive Officer Cablevision Systems Corporation Executive Chairman The Madison Square Garden Company Jennie Fortunoff Principal Esterow Events & Consulting, Inc. Anne Glauber Managing Partner and Founder, Corporate Social Responsibility and Social Impact Practice Finn Partners Kerri Kaplan Executive Director and Chief Operating Officer The Lustgarten Foundation Andrew Lustgarten Executive Vice President, Corporate Development and Strategy The Madison Square Garden Company Jessica Lustgarten Manager, Strategy and Analysis DigitasLBi Marcia Lustgarten Director, Optimum Community Cablevision Systems Corporation Sheila Mahony Retired Executive Vice President, Communication, Government, and Public Affairs Cablevision Systems Corporation Charles R. Schueler Executive Vice President, Media and Community Relations Cablevision Systems Corporation Adam Silver Commissioner National Basketball Association Robert F. Vizza, Ph.D. President and Chief Executive Officer The Lustgarten Foundation 20 • THE LUSTGARTEN FOUNDATION

John S. Hendricks Founder and Former Chairman Discovery Communications Mel Karmazin Retired Chief Executive Officer Sirius XM Radio, Inc. Co-Founder Infinity Broadcasting

David Paul Kelsen, M.D. Memorial Sloan Kettering Cancer Center Robert J. Mayer, M.D. Dana-Farber Cancer Institute & Harvard Medical School Bruce Stillman, Ph.D. Cold Spring Harbor Laboratory

Gerald M. Levin Retired Chief Executive Officer Time Warner, Inc.

David Tuveson, M.D., Ph.D. The Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory

John C. Malone Chairman Liberty Media Corporation

Bert Vogelstein, M.D. The Johns Hopkins University School of Medicine

Rupert Murdoch Executive Chairman News Corp Executive Co-Chairman 21st Century Fox Sumner M. Redstone Chairman Emeritus Viacom and CBS Corporation Chairman National Amusements Tom Rogers Non-Executive Chairman TiVo, Inc. Sir Howard Stringer Non-Executive Director British Broadcasting Corporation Retired Chairman of the Board Sony Corporation Bob Wright Retired Vice Chairman of the Board General Electric

Bill and Ellen Bell Cablevision Systems Corporation Charles B. Wang Foundation Mr. and Mrs. Frederick DeMatteis

Mr. and Mrs. Charles F. Dolan Mr. and Mrs. James L. Dolan Mr. and Mrs. Amos B. Hostetter Jr. Mr. and Mrs. John T. Lockton III

McMullen Family Foundation Mr. and Mrs. F.F. Randolph Jr. The Lustgarten Family Mr. and Mrs. Leonard Tow

CHAIRMAN’S CIRCLE $500,000 + Cumulative Since Inception AMC Networks Cablevision Systems Corporation Estate of Dorothy C. Guida Estate of Lucille L. Tirkfield Estate of Mary Brenneisen Estate of Maxine Stein-Kohler Estate of Patricia C. Galgan Estate of Roberta Coppola JCPenney Karen Zissu-Magidson Memorial Fund

KPMG, LLP Ruth and David Levine Levon Graphics Corporation Mr. and Mrs. John T. Lockton III Mark Broxmeyer Memorial Fund McMullen Family Foundation News Corporation Rolfe Pancreatic Cancer Foundation Shostak Charitable Fund The Bern Schwartz Family Foundation

The Lustgarten Family The Madison Square Garden Company The Walter B. Wriston Fund Theodore W. Batterman Family Foundation, Inc. Mr. Charles Wang

PRESIDENT’S CIRCLE $100,000 - $499,999 Cumulative Since Inception 21st Century Fox Amdocs Broadband Cable & Satellite Division Arris Ms. Adrienne Atkinson Mrs. Cornelia T. Bailey Bank of America Barbara Montani Santaniello Research Fund, Inc. Bear Stearns Companies, Inc. Bill and Ellen Bell Black Twig Communications, LLC Boston Scientific Corporation Brindell Roberts Gottlieb Trust Brisbin Brook Beynon, Architects Celgene Corporation Cisco Systems, Inc. Clare Rose Foundation, Inc. Mrs. Dorothy Daly Debevoise & Plimpton LLP Deloitte & Touche DevelopOnBox LLC Discovery Communications, LLC Disney and ESPN Media Networks Eli Lilly and Company ESPN, Inc. Estate of Florence E. Wilson Estate of John A. Ryvik Estate of Judith Bandel Estate of Laurie Lima Estate of Suzanne Rapier Fashion Accessories Benefit Ball

Forchelli, Curto, Deegan, Schwartz, Mineo & Terrana Frank J. Antun Foundation Mr. and Mrs. Ronald Frankel Frenz For A Cause, Inc. Frontier Touring Gardner Nelson & Partners, Inc. Genentech, Inc. George L. Ohrstrom Jr. Foundation Gibson, Dunn & Crutcher LLP Greater Hartford Community Foundation, Inc. Mr. Leo A. Guthart HJ Kalikow & Co., LLC HBO Hope Foundation Mr. and Mrs. Amos B. Hostetter Jr. Howard Shapiro Memorial Fund Hughes Hubbard & Reed LLP IBM Employee Charitable Contribution Campaign ImClone Systems Incorporated James S. Swinehart Memorial Fund John Alexander Wilkins III Memorial Fund JPMorgan Chase Jeffrey Rosenzweig Foundation For Pancreatic Cancer Research Jenner & Block LLP Jones Day Kansys, Inc. Kauff McGuire & Margolis LLP Kelley Drye & Warren LLP

Lazarus Marketing, Inc. Loeb & Loeb LLP Mr. and Mrs. Bruce Martin Merrill Lynch Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Miramax Films Morgan Stanley Morgan, Lewis & Brockius LLP MTV Networks, Inc. NBA Cares NBCUniversal Neil M. Klatskin Foundation, Inc. Newsday Nokia Siemens Networks OSI Foundation Paul, Weiss, Rifkind, Wharton & Garrison LLP Mr. Robert F. Penardi Pharmacia & Upjohn Co. Port Jefferson Yacht Club (formerly Setauket Yacht Club) Mrs. Richardson Pratt Jr. Mrs. F.F. Randolph Jr. Ropes & Gray LLP Mr. and Mrs. David E. Salmanson Samsung Mrs. Kathryn Schulberg Scientific-Atlanta, Inc. Shearman & Sterling LLP Showtime Networks, Inc. Mr. Adam Silver ANNUAL REPORT • 21


Tom's Cure Pancreatic Cancer Foundation Mr. Leonard Tow Turner Broadcasting Systems, Inc. UBS Financial Services, Inc. Mr. and Mrs. Mark Udell of London Jewelers Verizon Communications Viacom Virginia Grande Schwenk Wasily Family Foundation West New York Restoration of CT, Inc. William Morris Endeavor Entertainment Willkie Farr & Gallagher LLP WLNY TV 10/55 Suzanne and Bob Wright

This listing reflects the total amount of donors’ commitments from January 1, 2015 to December 31, 2015, including gifts, pledges, and payments on prior-year pledges of $1,000 or more.

Cablevision Systems Corporation Celgene Corporation Estate of Dorothy C. Guida Estate of Laurie Lima Estate of Mary Brenneisen Estate of Patricia C. Galgan George L. Ohrstrom Jr. Foundation Mark Broxmeyer Memorial Fund Rolfe Pancreatic Cancer Foundation The Antoinette E. (“Mimi”) & Herman Boehm Foundation The Bern Schwartz Family Foundation The Walter B. Wriston Fund Theodore W. Batterman Family Foundation, Inc. Virginia Grande Schwenk Suzanne and Bob Wright

PLATINUM CIRCLE $50,000 - $99,999 21st Century Fox Arris Bank of America Boston Scientific Corporation ESPN, Inc. Estate of Richard Spinolas Estate of Rona Brozen Gibson, Dunn & Crutcher, LLP Greater Hartford Community Foundation, Inc. Hope Foundation Kauff McGuire & Margolis LLP KPMG, LLP Ropes & Gray LLP Mr. Adam Silver Sullivan & Cromwell LLP The Charles B. Wang International Foundation The Henry and Marilyn Taub Foundation 22 • THE LUSTGARTEN FOUNDATION

The Madison Square Garden Company The Ralph C. Marcove Cancer Research Fund, Inc. Wasily Family Foundation Verizon Communications

GOLD CIRCLE $25,000 - $49,999 AMC Networks Data-Mail, Inc. Debevoise & Plimpton LLP Deloitte & Touche Discovery Communications Estate of John Alexander Wilkins III Estate of Thomas J. Furlong Jr. Estate of Thomas Zimmerman Mr. Robert P. Flicker Foundation For A Better World, Inc. Mr. and Mrs. Kenneth Fuirst Hughes Hubbard & Reed LLP Infinera Corporation IWCO Direct James S. Swinehart Memorial Fund JPMorgan Chase Jenner & Block LLP Karen Zissu-Magidson Memorial Fund Ruth and David Levine Linda J. Verville Cancer Research Foundation Dr. Edward Loeb and Family Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Morgan, Lewis & Brockius LLP NBA Cares NBCUniversal Neptune Township - NJ Patterson Belknap Webb & Tyler LLP Paul, Weiss, Rifkind, Wharton & Garrison LLP PJT Partners Port Jefferson Yacht Club (formerly Setauket Yacht Club) Pound The Pavement

Mr. and Mrs. Peter C. Richardson Samsung Mr. and Mrs. Gregory Seck Showtime Networks, Inc. The Benevity Community Impact Fund The Clarissa & Edgar Bronfman Jr. Foundation The Richard E. Capri Foundation Time Warner, Inc. Mr. and Mrs. Mark Udell of London Jewelers Zodiac Interactive

SILVER CIRCLE $10,000 - $24,999 A & E Television Networks Aaliyah Memorial Fund, Inc. Abbe Berman Foundation Trust Access It Group AI Media Group, LLC Alcatel-Lucent Amdocs Broadband Cable & Satellite Division Andree Wildenstein Dormeuil & Roger Dormeuil Foundation Ms. Adrienne Atkinson B&F Johnstone Supply Baldor Specialty Foods Barclays Capital

Thomas Cifardi

DIAMOND CIRCLE $100,000 +

Mrs. Linda K. Berger Bethpage Federal Credit Union Bloomingdale, NJ Fire Department BNP Paribus Mrs. Barbara A. Bradley Breakfast Club Foundation Brisbin Brook Beynon, Architects CamberView Partners Carol B. Smith Memorial Golf Fund Mr. and Mrs. Richard L. Chadakoff Charles and Margaret Levin Family Foundation, Inc. Cisco Systems, Inc. Citigroup Payment Services Clare Rose Foundation, Inc. Connect One Creative Bath Products, Inc. Croatian American Charitable Foundation, Inc. Ms. Mary C. Dix D-Link Systems, Inc. Mr. and Mrs. Lawrence J. Dolan Donatic Dorothy “Dot” Robelen Memorial Fund Mr. and Mrs. Eric Dusansky Egon Zehnder International, Inc. Dr. Joan Egrie Elaine Levy Ordower Foundation Ms. Debbie Elder Entertainment Industry Foundation EPIQ Systems, Inc. Estate of Helen Weaver Estate of I. Edward Picker Estate of Suzanne Rapier Fadeaway Records Richard and Mary Felix Charlotte and Jeremy Fletcher Forchelli, Curto, Deegan, Schwartz, Mineo & Terrana Frank J. Antun Foundation Mr. Gerald Frankel Mr. and Mrs. Ronald Frankel Mr. and Mrs. Ross Frankel Genentech, Inc. Gerstner Family Foundation Mr. Zale Glauberman Go With Courage, Inc. Goldman, Sachs & Co. Mr. and Mrs. Steven Goodman Guggenheim Partners Mr. Michael J. Halperin and Family

Mr. Roger Hathaway Haymakers for Hope, Inc. HBO Houlihan Lokey Howard Shapiro Memorial Fund Laura and Brian Hull IBM Corporation IBM Employee Charitable Contribution Campaign iHeart Media J.T. Hobby Jr. Endowment Fund John Crain Kunkel Foundation Kansys, Inc. Kasowitz, Benson, Torres & Friedman LLP Mrs. Marilyn Kasperick Kelley Drye & Warren LLP Mr. Kerry J. Kirby Mr. Howard M. Krams Lawton Adams Construction Lenovo Lightpath Luau For Pancreatic Cancer Lydia K. Feidler Charitable Trust Martha Washington Straus-Harry H. Straus Foundation, Inc. Mr. and Mrs. Bruce Martin Max and Sunny Howard Memorial Foundation McMullen Family Foundation MediaLink Michael Abelon Memorial Foundation Inc. Mr. and Mrs. Stephen E. Milstein Miranda Fund Morgan Stanley MRV Optical Communications Systems MUFG Rafal Murczek National Hockey League NetScout Systems, Inc. Network For Good Mr. Steve Novenstein Mr. Jeffrey Paraschac PHD Network Mr. and Mrs. Neil Pirozzi Mr. and Mrs. Fred Poses Mr. Andrew Prekopa Mrs. F.F. Randolph Jr. Rensselaer Honda’s Tom Gorman Memorial Golf Outing Mr. Donald M. Robelen Russell & Katherine Hawken Foundation RVM Enterprises, Inc. Sagemcom Mr. and Mrs. David E. Salmanson Sandvine Sandy Alexander Ms. Patricia Schwarz SCI Architects PC Scotia Capital Scripps Networks Interactive SevOne, Inc. Shostak Charitable Fund Mrs. Judith Siegfried Sloane & Company

Stanley Shalom Zielony Foundation Dr. and Mrs. Mark R. Sultan Mr. and Mrs. Daniel S. Sundheim Sutherland Global Services TD Securities (USA) Inc. The Brooklyn Brothers LLC The Ergonomic Group The Hildenbrand Family Foundation The Jacqueline Jackson Charitable Account The John G. Bolos Charitable Gift Fund The Lustgarten Family The Maria Young Memorial Fund The MaryAnn and Gordon Rich Family Charitable Fund The Paul B. Greetin and Beryl S. Greetin Foundation, Inc. The Peter Grosslight Memorial Fund The Robert & Lynne Grossman Family Foundation The Robert and Marion Schamann Brozowski Foundation The Sandra Atlas Bass and Edythe & Sol G. Atlas Fund, Inc. The Schwartz Family Foundation The Spionkop Charitable Trust The West Endowment Tishman Speyer Tom's Cure Pancreatic Cancer Foundation Truist Mr. Robert S. Trump Turner Broadcasting System, Inc. UBS Financial Services, Inc. Univision Communications Ms. Courtney C. Van Auken

Joseph Kellard

The Mark Abrams Memorial Foundation The Perelman Family Foundation, Inc. The Peter Grosslight Memorial Fund The Ralph C. Marcove Cancer Research Fund, Inc. The Richard E. Capri Foundation The Robert & Lynne Grossman Family Foundation The Sandra Atlas Bass and Edythe & Sol G. Atlas Fund, Inc. The Weinstein Company The William H. Isacoff, M.D. Research Foundation Thomasville Home Furnishings Metro NY Time Warner, Inc.

Ben Asen

Sloane & Company Stephen & Mary Birch Foundation Sullivan & Cromwell LLP Sun Microsystems The Antoinette E. ("Mimi") & Herman Boehm Foundation The Benjamin Neuhausen Fund for Pancreatic Cancer Research The Bernice and Milton Stern Foundation The Harry T. Barbaris, M.D. Memorial Fund The Lefkofsky Foundation The Mancheski Foundation, Inc. The Marc Haas Foundation

VeEX Inc. VMware Foundation W.L. Landau Ethan Allen Mr. and Mrs. Timothy J. Walsh Mrs. Traci A. Weaver Mr. and Mrs. Mark Weinstein West Haven, CT Elks Lodge #1537 Hope and Gavin Wolfe The Wolf Family Mr. and Mrs. Chuck Yablon Mrs. Monica Yandow ANNUAL REPORT • 23


Andrea's Adventure Apex Systems Inc Mr. Joseph L. Arena Mr. Lawrence T. Babbio Bahnik Foundation, Inc. Bank of America Charitable Gift Fund Employee Giving Mr. Joel Barnett Mrs. Evelyn Barrow Battelle Memorial Institute Becker Harrow Bicitis Group, Inc. Ms. Susan Bick Billy Webber Memorial Fund, Inc. Mr. and Mrs. Richard Blomquist Bloomberg TV Boas Family Fund Mr. Robert M. Bortell Brian McGovern Memorial Golf Tournament Mr. and Mrs. Tom Burnett Carol & Jack Kline Fund Mrs. Carolann Catalogne Mr. Robert B. Catell Century Bank Ms. Alana Clegg Clifford Chance US LLP Mr. Howard Cohen and Family Mr. and Mrs. Douglas Cooper Ms. Mary Ann Crutchlow Mr. and Mrs. Gary Damast Davis Wright Tremaine LLP Mr. Thomas F. DeGrazia Mr. and Mrs. Michael S. Dernburg Dreamline DSW Inc. 24 • THE LUSTGARTEN FOUNDATION

Long Valley Village Association Loren Findorak Memorial Golf Outing Ms. Rosalind Massow Luger Mr. and Mrs. Andrew Lustgarten Magda and Edward Bleier/Dana Foundation Marino Family Charitable Foundation, Inc. Mark and Gayle Lerch Family Foundation Maureen Data Systems, Inc. Ms. Christa Meinzinger Mr. Richard Melchner and Family Mr. Don Middleberg Mrs. Diane Miller and Family Ms. Phyllis W. Miller Mohegan Sun Mr. and Mrs. Craig Moore Mr. Stuart M. Morgan and Family New York Thoroughbred Horsemen’s Association, Inc. Nokia Siemens Networks Ms. Heidi J. Nolte Omega Fi Oracle Pat Hall Management Group, Inc. Mr. Doniel Perl Phoenix Communications Pine Hollow Charity Fund, Inc. Ms. Lynn G. Platzner and Family Mr. and Mrs. Hy Portnoy and Family Mr. John J. Powers PPC Broadband, Inc. Mr. and Mrs. Salvatore J. Pranzo and Family Property Resources Corporation Proskauer Rose, LLP R.F.E., Inc. Mr. and Mrs. Gil Raviv Ms. Dolores Riordan Roberta and Gary Fisher Charitable Fund Mrs. Andrea Rosenfield and Family Mr. James Rowley RSU PayFac Schenck, Price, Smith & King LLP Mrs. Anne Schnesel Score For The Cure in Pennington, NJ Scott and Susan Davidson Foundation, Inc. Sherry Shumaker Memorial Fund

Siena Engineering Group, Inc. The Silvestrone Family Dr. Hilma M. Yu and Mr. Anthony M. Sola Mr. and Mrs. Laurence Sperry SportsNet New York Starz Entertainment Dr. Zelig Steinberg and Mrs. Pamela J. Steinberg Sterne, Kessler, Goldstein & Fox PLLC Stop & Stor Charitable Fund Mrs. Stephanie F. Strauchen Suntrust Robinson Humphrey Mr. Martin E. Tanzer and Family Team Krause Technology Solutions, Inc. TEK Systems The Gettinger Family Foundation

BENEFACTOR $2,500 - $4,999 58A JVD Industries, Ltd. A. J. Bart & Sons Mr. and Mrs. Josh Aaronson Mr. and Mrs. Neil Aaronson Mr. Laurence J. Abzug Mr. Howard Adler Mr. Darel C. Agresta AIG Matching Gifts Program Ms. Lynn Allen AmazonSmile Foundation Andrea Anastasio Charitable Fund Ancient Order of Hibernians Div. # 2 Anything For A Friend Foundation Mrs. Nancy Armstrong Arthur J. Finkelstein & Associates, Inc. Baker & McKenzie LLP Ms. Martha G. Bannerman Bath Authority, LLC Mr. and Mrs. Paul Bergman Mr. Jay D. Bienstock and Family Mrs. Phyllis Bilus BNY Mellon Wealth Management Ms. Linda Boss Ms. Taryn Bostjancic Mr. Lawrence Botel Brown Rudnick BTIG, LLC Mr. Chris Buonanno Mr. Dennis Burt Ms. Sara L. Cahill Cancer Treatment Centers of America Eastern Regional Medical Center Canter For The Cure Cellini Charitable Foundation, Inc. Mr. Gary A. Chanowitz Charles A. Dailey Foundation Classic Audi Mr. and Mrs. Laurence J. Cohen Mr. Peter Cohen Dr. and Mrs. Wayne T. Cohen and Family Ms. Wendy Cohen Ms. Donna M. Coleman

Competition Dynamics, Inc. Contec Holdings, Ltd. Cooper & Schall, P.C. Mr. and Mrs. Stephen Corman Credit Suisse First Boston CustomInk LLC Mr. and Mrs. Jeff Danker Mr. and Mrs. Peter Desmond Deutsche Bank Americas Foundation Matching Gifts Program Donnelly Mechanical Corp. Mr. and Mrs. Adam Donner Douglas Elliman Real Estate DST Output E R Bane Trust The Ebertz Family Mr. Scott Eichel Espalier Global Estate of Rita Cristofani Evening Out, Inc. EyeKrafters Medical Optics, P.C. F5 Networks Five Prime Therapeutics, Inc. Mr. Frank Fortino Ms. Helene Fortunoff Ms. Jacqualyn A. Fouse Mr. Andy Frank Mr. Charles Frankel Anita Dann Friedman Friends of John V. Duffy Fross Zelnick Lehrman & Zissu, P.C. Fusion Media Mr. and Mrs. Gregory Gannon Mr. Lawrence J. Gannon Mr. John J. Garthoeffner Mr. and Mrs. Dave Girolamo Ms. Gail Gittleson Ms. Anne F. Glauber Glen Oaks Club Barbara and Abdel Ghafir Mr. Michael Greengarten Greenwich Hospital H2 Consulting, Inc. Ms. Gail F. Harms Hauser's Truck Service Dr. Jason T. Heckman Mr. Harvey R. Heller Mr. Merrit Heminway Hershey Family Fund Mrs. Lauri Hidalgo and Family Hogan Lovells US LLP Home Depot Foundation Matching Gifts Honorable Golfers of 2015 Sycamore Tournament Mrs. Inge Horn Mrs. Loretta E. Howard Ms. Amy Hunter ICRAVE, LLC iN DEMAND J. Horowitz and E. Hardin Fund Jack Haley Memorial Fund Ms. Beverly S. Jacobs Mr. Perry Jacobson Joseph F. Stein Family Foundation, Inc.

Juniper Networks Dr. Frank M. Kamer Mrs. Louise Kaminow and Family Mr. Jeffrey Kan Mr. Marc Karetsky Mrs. Dolores Karp Mr. Christopher Kete and Ms. Tiffany George-Kete Ms. Nancy Kieffer Mr. and Mrs. Ron Kisner Mr. and Mrs. Brad Kitchens Mrs. Kathy Klauda Knights of Columbus No. 5989 Kobre & Kim LLP Nicole and Stuart Kovensky Mrs. Yolanda J. Kunz The Kurman Family Mr. Douglas E. Lantz Mr. and Mrs. Michael E. Laub Laurie Milotte Memorial Fund Ms. Marianne Lazarou Mr. Brian D. Leaghty Mrs. Elizabeth P. Levengood Mrs. Renee Lockhart LogicPrep

Photo courtesy of the Towle Family

Barbara Trainor

Mr. and Mrs. Roger Abramson Adam Levine Productions Alliantie Technical Group, Inc Ambrosio & Bellotti Charitable Foundation Inc. American Express Foundation Employee Gift & Matching Program

Dun & Bradstreet Edward Darman Co., L.P. Estate of Doris Schumer Estate of Roberta Coppola Farrell Fritz, P.C. Fathom Communications LLC Fifth Avenue of L.I. Realty Association Foremost Footwear LLC Ms. Ruth Fortunoff-Cooper Jennie Fortunoff and Andrew Chonofsky Fox Networks Fox News Channel Mr. Sidney Friedman GE Foundation Matching Gifts Program Gene Toth Memorial Fund Giuseppe Nigro Home Lodge 2234 Gleason Family Foundation, Inc. Mr. Keith Goggin Goldman Sachs Gives Goldman, Sachs & Co. Matching Gift Program Mrs. Bernice L. Gotlieb Gracenote Ms. Courtney Granville and Mr. Daniel Rosenthal Ms. Rona M. Guidone Mr. Jeffrey Gural John and Julie Hamre Hanover Park High School Harkavy-Mack Foundation Haynes and Boone, LLP Mrs. Deborah Heidecorn and Family Heritage High Point Utilities Mrs. Debi Hills and Family Mr. Ronald Hohmann Horwith Trucks, Inc. Insurance Auto Integrated Broadband Services, Inc. Intex Solutions, Inc. Irwin Chafetz Family Charitable Trust Mr. and Mrs. Jon Iwata Mrs. Sylvia Jacobs and Family James & Eileen Bruce Foundation Jaros Baum Bolles Consulting Engineers Jayco JFK Air Cargo Association, Inc. Joann Weber Charitable Fund of the Greater Lowell Community Foundation Johnson & Johnson Matching Gifts Program & Employee Funds Mr. and Mrs. Philip Johnson Mr. and Mrs. Michael Kabat Mr. and Mrs. Armenag Kalaydjian Mrs. Carrie Kelley Mr. Scott W. Kilrea Mr. and Mrs. Kenneth Klein Ms. Mary Klim Mr. Patrick E. Law Mr. and Mrs. Joe Lawrence Liberty Mutual Employee & Matching Gift Program Tobey Lipschitz

Joseph Kellard

BRONZE CIRCLE $5,000- $9,999

Mrs. Marie Lopez Lord & Taylor Ms. Helen Lowenstein Mr. Michael Mackey Mrs. Chrissy M. MacTaggart Mrs. Thane Malison Mayer Brown LLP Mr. Doug McDaniel Melvin R. Goodes Family Foundation Merck Partnership For Giving Microsoft Matching Gifts Program Ms. Jean Miller Mr. Max Miller Mr. Paul W. Moderson Montauk Sports, Inc. Montefiore Health System Mr. Quinn Montgomery Ms. Jo Ellen Moore Moritt Hock & Hamroff LLP Mountain Empire Oil Company ANNUAL REPORT • 25


Ben Asen

PATRON $1,000 - $2,499

Mr. Jeffrey Ross Mr. Matthew Schwartz Sellers Publishing, Inc. Mr. and Mrs. Steven E. Sesterhenn Mr. Bradley Setser F. Shanks Mr. Thomas Shapiro Mr. Bradley N. Shippert Shoreline Brewery & Restaurant Dr. and Mrs. Anthony Sifonios Sirius America Insurance Company Mrs. Abby Smith Steel Equities Mr. Mark J. Stein Steiner Sports Memorabilia, Inc. Mr. Robert Stone Mr. Joseph M. Sullivan The Aboodi & Hoffman Families The Frank J. Romano Foundation, Inc. The Amy Udell-Mauskopf Family 26 • THE LUSTGARTEN FOUNDATION

538 Driggs Avenue Corporation A & D Restorations, LLC A.C. Israel Foundation Ms. Solange Abbate Mr. and Mrs. Milton B. Adams Advanced Fiber Works, Inc. Advent, Inc. Aetna Mr. Donald J. Aharonian Albany Gastroenterology Consultants, PLLC Mr. and Mrs. Andrew Alberti Ms. Kiersten Albrecht and Family Mr. and Mrs. Havard Albright Mr. and Mrs. David Albritton All Phase Construction Group, Inc. Alliance Bernstein LP Mr. and Mrs. Donald Allman Alma DDB American Metals Supply Co., Inc. AmWINS Brokerage Analysis Research Planning Corp. Ms. Quinta E. Andersen Annelise Peterson Winter & David S. Winter Anthem Sports and Entertainment Corp. Mr. Graham Anthony AON Risk Services, Inc. of NY ARCCA, Inc. Mr. Robert Arconti Arlindo and Evelyn Jorge Family Trust Armrod Charitable Foundation Mr. and Mrs. David Arnow

Artemis Gallery Artexture Mr. Anthony Arturi and Family Mr. Veeraraghavan Arun Mrs. Margaret Asselin AT&T United Way/Employee Giving Campaign Mr. and Mrs. Edward C. Atwood ATX Networks Mr. B. Reuben Auspitz and Ms. Dawn K. Good Elk William and Augusta Austin AXA Foundation Mr. and Mrs. Alan Azralon Bacchus Importers, Ltd. Mr. Brian Bae Mr. Robert Bagdorf Bank of America Foundation Matching Gifts Mr. and Mrs. Steven C. Bardwil Ms. Keri Barmak Barnabas Health Behavorial Health Center Mr. and Mrs. Adam Barnett Mr. Troy Bartley Mr. William Bassett Mr. and Mrs. Michael E. Bauer Mr. Dennis Bavaria Mr. Steven Beberman Ms. Roz-Lynn Beckenstein and Ms. Julie Beckenstein Ms. Ellen Becker and Mr. Howard Hamburger Jeffrey and Barbara Becker Mr. Michael Becker The Bedard Family Bedford High School Volleyball Team Ms. Virginia Bedford Mr. Arthur D. Bellini Ms. Jill Bender Dr. and Mrs. Chester A. Bennett Mr. Gary M. Bennett Berdon LLP Mrs. Lori Berisford Mrs. Karly Berman Mr. Douglas Bernstein Rick and Jane Bernstein Dr. Wendy B. Bernstein Mr. Michael Berr Bill and Ellen Bell Bill Tamburro Jr. Memorial Golf Tournament Mr. Richard S. Birnbaum Mr. Steven Bissonnette Ms. Marlene Bittman and Family Black Pearl BlackRock Matching Gifts Program Blechman-Morenoff Foundation, Inc. Blue Ridge Capital, L.L.C. Ms. Joanne Blum Mr. and Mrs. Stuart Bobry Mr. Mark Bodie and Ms. Kristine M. Ryan Ms. Candice R. Bolte The Bonde Family Ms. Laura Boothe

Borax Paper Products, Inc. Mr. Mitchell F. Borger Ms. Jessica Borowick Mr. John Boruta and Family Dr. Harriet S. Boxer Bob and Tammi Brady Mr. and Mrs. John B. Brand Ms. Margaret A. Brand Mrs. Bernardine Brandis Mrs. Marie Brausam Mrs. Laura Brehmer Bretton Woods Golf Club BRIC-TPS, LLC Bridgewater Associates, LP Bristol-Myers Squibb Foundation Broadridge Financial Solutions, Inc. Broadridge Foundation Matching Gifts Program Mr. and Mrs. Mark Brosky Mr. and Mrs. Michael J. Brown Peter and Sandy Bruhn Mr. Kenneth Bruley Brut LLC Mr. Richard A. Buchanan Andrew and Jodi Buchbinder Mr. and Mrs. Mitchell I. Buchbinder Buckley Brothers, Inc. Mr. Edward H. Budd Budget Blinds of Ossining, NY Mr. and Mrs. John P. Buechler Bulldog Ventures, Ltd. Mrs. Angela Buonocore Wilkins Mrs. Jan L. Burch Mrs. Gwen Burtch-White Burton & Rose Kahn Family Foundation Mr. Mark Byrne Ms. Maryanne C. Byrnes CA, Inc. Matching Gifts Program Mr. John T. Cahill CAK Entertainment California Association of Health Facilities Mr. Ryan W. Callas Callaway Volunteer Rescue Squad Ms. Jo-Ann Cambareri Cancer Treatment Centers of America Western Regional Medical Center Mr. John T. Carey Mrs. Hayley B. Carlson Mr. and Mrs. Bob Carniaux The Carnogursky Family Mr. Douglas R. Carpenter Ms. Boi Carpenter-Mellady Mr. Freddy Carrano and Family Mrs. Anne Caruso Casa Systems, Inc. Mr. Douglas Castoldi Ms. Joann Catalano Mr. and Mrs. Joseph J. Catapano Mr. Dennis M. Caulfield Cavallo Family Foundation CBRE Cares Century Mortgage Company Ms. Shari Cerini

Mr. and Mrs. Aaron J. Chaitovsky Ms. Andrea Chambers Changing Our World, Inc. Charles M. Cappellino Foundation, Inc. Mr. Thomas Cherner and Ms. Lynn A. Suter Chleck Family Foundation, Inc. Mr. William J. Christ Mr. and Mrs. Thomas E. Christman Chubb & Son, Inc. Matching Gifts Program Mrs. Susan Cicala Mr. Thomas A. Cifardi Circle of Hope Bracelets, Fran's Hope Foundation Cisco Capital Citco Fund Services (USA), Inc. Mr. and Mrs. Warren L. Clark Clarkson Construction Company Mr. Montgomery C. Cleworth CoBank Mr. and Mrs. John Cobb Mrs. Sharon Cobb Code 3 For A Cure Foundation Mr. Jeffrey Cohen Mr. Martin Cohen Mr. Steven M. Cohen Mr. Charles E. Colander Ms. Gail Coleman Mr. Harry A. Coleman II Mr. William H. Coleman Mr. Brian Colgan Collection Bureau of the Hudson Valley, Inc. Ms. Valerie Colon Mr. and Mrs. Marcel G. Comire CommScope Complete Leasing Systems, Inc. Ms. Barbara Congema Mr. Charles Connors Mr. and Mrs. Ben Conte Mrs. Georgia Cooper and Family Mr. and Mrs. Bill Cooper Mr. Jordan Copland Ms. Loretta R. Cormier Ms. Kim Cornell Mrs. Maureen Cornicelli and Family Corning Optical Communications R. Cosentino Ms. Linda Cote Mr. Bob H. Cox Credo, LLC Mr. and Mrs. Robert Crimmins Mr. Eric Crockett Mr. Brian Crowley Crown Media Family Networks Ms. Sarah Cummings Mr. and Ms. John J. Curley Mrs. Pamela Currey Mr. and Mrs. Errol Cvern Mr. John Czajkowski Dallastown Area Basketball Booster Mr. Peter Dalton Mr. and Mrs. Philip G. D'Ambrosio

Joseph Kellard

The Riese Organization The Road Knights Auto Club, Inc. The Thalia and George Liberatos Foundation The Walt Disney Company Foundation The Weiser Philanthropic Foundation The William and Sylvia Silberstein Foundation, Inc. Thrivant Time and Again, Inc. Mr. Alexander Tisch Mr. Raphael Toledano Mr. Michael Tramontano TV Guide Network U.S. Bank UBS Matching & Employee Gifts Program University of Colorado Hospital Waldner's Business Environments Mr. Paul W. Watson Jr. Mrs. Carol Whalen and Family William Goldberg Diamond Corp. Ms. Megan Wisdom Mr. Larry J. Wyman Dr. and Mrs. Charles Zugerman Ms. Karen Zupko ZwillGen PLLC

Mr. Michael Damken Mr. Michael P. Damm Mr. Lyell Dampeer Danella Line Services Co., Inc. Ms. Roberta Danza Daphne I. Panagotacos M.D. Inc. Mr. Rick Dastin Davidoff Hutcher & Citron LLP Mr. Thomas Deese Mrs. Naima Dennis Dentalle, Inc. Dr. Kumar Desai Mr. Adam DeSanctis Mr. and Mrs. Harris Diamond Mr. and Mrs. Randy J. Diamond and Family Mr. John DiDomenico Ms. Jodilynn DiPiazza Discover Financial Services Doctors Express Mr. David M. Dolan Ms. Lorna T. Donatone Mrs. Louise Donnelly Mr. and Mrs. Herbert C. Donner Ms. Sandra L. Dosick Mr. Stephen M. Dowicz Mr. Vincent B. Dowling Mr. John P. Dries Dropbox Mrs. Katherine Druley-Herron Dunkin’ Donuts of North Grafton, MA

Barbara Trainor

Ms. Catherine R. Nathan Mr. and Mrs. J. Michael Nolan Old Westbury Golf & Country Club Mr. and Mrs. Kirk Oliver Mrs. Erika L. Padgett Patricia Armstrong Dressler Foundation Mr. William G. Paullin Perception Research Services Inc. Perfect Vision Manufacturing Inc. Phillips-Van Heusen Foundation, Inc. Mr. Jack R. Pine Mr. and Mrs. Jeffrey L. Pliskin Price Family Fund Dr. Nathan T. Pruitt Punch Out Pancreatic Cancer Quan, LLC RAD Communications Ms. Laurice Rahme Mr. Henry P. Randall IV Ms. Georgia Renne Mr. Gerry M. Ritterman Mrs. Eve K. Robinson and Mr. Joshua Wiener Rock Hill Golf & Country Club Mrs. Cheryl Ross and Family

ANNUAL REPORT • 27


Mrs. Stacey Evans Everyday Hero F & F Hardware and Supply, Inc. Ms. Andrea Fairhurst Mr. Martin G. Farber Dr. and Mrs. David Fastenberg Mrs. Rozanne T. Faulkner Mr. Charles M. Fegley Drs. Randall and Sheryl Feingold Mr. George Fekete Mr. Greg Feldman Mr. Jonathan Feldman Mr. and Mrs. Ross Feldman Mr. William Felton Ms. Phyllis Fenster Mr. Joseph Feshbach Neal and Phyllis Finkelman Mr. Steven Finkelstein FirstGiving Dr. and Mrs. Joel Fischer and Family 28 • THE LUSTGARTEN FOUNDATION

Mr. Mark Fischer Mrs. Francine Flamino Ms. Wendy Flanagan Mr. and Mrs. Rob Fleder Mr. Wayne S. Flick Mr. Michael Flood Foley & Lardner LLP Charles A. Forma, Esq. Timothy Foster FosterThomas, Inc. Mrs. Sandra Fout Foxwoods Resort Casino Mr. Bruce D. Frank Mrs. Nina Frankel Mr. Carl Frascogna Mr. and Mrs. Avram C. Freedberg Mr. Walter Freeman Friedberg Pinkas PLLC Mr. Andrew H. Friedman Mr. Edward A. Friedman Mrs. Elizabeth Friedman Friends of Stu Freed Mr. and Mrs. Tom Fullerton Mr. Tiberio Furtado Mr. and Mrs. Matthew Gaier Mr. and Mrs. Kenneth Gamble Joe and Mary Gardill Mr. Mark Garten Mr. John M. Gaynor Dr. Clyde Generoso Geraldine R. Dodge Foundation, Inc. Mr. Kenneth Gideon Mr. Bruce Gifford Ms. Adrienne Gilberg Mr. and Mrs. Cliff Gilbert-Lurie Mr. Josh Gillon and Family Giomare Group LLC Mrs. Geri Giorgio Mr. Jay T. Glassman Mr. and Mrs. Marc Glenn Sam and Emily Glick Mrs. Katherine Gohdes Mrs. Sherry Gold Ms. Sarah L. Gold Jesse A. Goldberg Mr. and Mrs. Arthur Goldfrank Ms. Katja Goldman Dr. Lawrence Goldman The Goldsmith Family Mrs. Danielle Goldstein Ms. Meryl S. Goldstein Richard & Candy Goldstein Ms. Shirley I. Goldstein Mr. William Goldstein Golf Tournament at Pine Hills Mr. Ernest Gomez Mr. and Mrs. Russ A. Goodman Ms. Kristin M. Gorman Mr. Peter Gormley Mr. and Mrs. Bruce Gorsky Mrs. Jackie Gosin Mr. and Mrs. Peter Gottlieb Mr. and Mrs. Peter Goulding The Gray Family

Greater Saint Louis Community Foundation Mr. Mark Greb and Family Green Valley Cooling & Heating, Inc. Ms. Madge Greenblatt Joseph L. Greene and Family Mrs. Pamela W. Greenstein Mr. and Mrs. Bruce Greenwald Mr. and Mrs. Bryan Greenwald Ms. Jane Griffith Ms. Marie “Meg” Griggs-O’Connor Mr. Marc Grill Mrs. Regina Grim Ms. Terry Groll Ms. Marlene Gromis Joan and Stuart Gross Groupon Mr. Bernard Groveman Mr. and Mrs. Abe Gruenwald Mrs. Annelies Guglberger Mr. Cole Gunter Dr. Michael Guttenberg Hackensack University Medical Center Ms. Teresa H. Hacunda Mr. Thomas E. Haeckel Ms. Margaret L. Hagen Mr. Frank J. Hague IV Mr. Drew Hahn Mr. and Mrs. Peter R. Haje Mr. Patrick Hall Mr. Thomas A. Hall Mr. and Mrs. Steve Hammerman Mrs. Martha Handler Ms. Elizabeth Hansen Mr. Brent D. Hardgrave Dr. John A. Harman Harmonic, Inc. Ms. Pamela M. Harper Mrs. Ikeyona Harvey-Jones Mr. Jeffrey K. Hass Dr. Caryn Hasselbring Haugebak Construction Co. Mrs. Karen Hawes and Family Mr. Spencer B. Hays Mr. Christopher B. Hayward Mr. Steve Heckler Mr. Raymond Hedaya Mr. Edward Heffner Mr. Stanley Heilbronn Hemisphere Media Group Ms. Kristi Henslin Mr. and Mrs. Paul Herbert Ms. Ilissa A. Herskowitz Ms. Cheryl Heuring Mr. Alan Hinds Hisco Mr. and Mrs. Jonathan Hitchcock Mr. Jordan Hoch Mrs. Susan C. Hoddinott Hills Mr. and Mrs. Richard Hoffer Hoffman Enterprises Ms. Victoria Hohmann Jim and Judy Hoke and Family Ms. Elizabeth E. Holle

Mr. Marc Holt HomeServe Mr. Freddy Hondo Ms. Terry Horowit Mr. and Mrs. Craig M. Horowitz Mr. Troy D. Horstman Ms. Mary Ann Horvath Mr. Michael F. Horwith and Family Mrs. Joyce G. Houlihan Mr. Robert J. Hrebek Mr. Frank N. Hughes Ms. Ingrid Hughes Humanscale Mr. Ed Y. Hung Mr. Denis Hurley Hylan Datacom & Electrical, Inc. IDI Gazely Mrs. Amy Iles Immaculate Heart Academy Independent Investment Group LLC Industrial Cooling Infosys Limited ION Computer Systems Iowa Classic Horse Show Mr. and Mrs. John M. Ivanoski J. Roger Newstedt, M.D. Family Fund Jackel Capital Inc. Dr. Mitchel Jacobs Ms. Sharon H. Jacquet Mr. Bruce Jaffe Mrs. Linda M. Jayne Jeff Horstman Golf Tournament Jemcap LLC Mr. John B. Jenkins Mr. Keith Jepsen and Ms. Kathleen Dore Jerrold A. Salmanson Foundation Mr. and Mrs. Daryel L. Jesperson Mr. Manish Jhanji Jim Alberto Memorial Golf Classic Joao Teixeira Memorial Fund John Scotts Inc Mrs. Jaqueline M. Johns Mr. Leonard A. Johnson Ms. Shirley K. Johnson Mr. and Mrs. Thad Johnson Mr. and Mrs. William Jordan JPMorgan Chase & Co. Foundation Matching Gifts Program Dr. Tina Jupiter JustGive.org K&L Gates LLP Ms. Maxine Kabol Mr. Alex Kahen Mr. and Mrs. Bahman Kamali Mr. Harold N. Kamine Mr. Gary M. Karlitz Ms. Daryl Karter Mr. Burton R. Kassell Mr. Gary Katcher Mr. Steven Katz Mr. Ronald A. Kaye Mrs. Amy Kealey Keith J. Lamphere - DBA Lamphere’s Truck Parts

Kenley Realty Company Mrs. Suzanne N. Kennedy Mr. William J. Kenney Mr. Alan Kessler Mr. and Mrs. Jim Kewley Ted and Laura Kiesewetter Mr. William Kilinskas Mr. Michael Kimak Mr. Stephen Kincade Kirkland & Ellis Foundation Mr. Bradford L. Klein Mrs. Sandi Klein Mr. and Mrs. George M. Klett Ms. Elizabeth Kline Ms. Nancy Kline Mr. Thomas S. Knowles Mrs. Barbara R. Kokot Ms. Agnes E. Kovacs Mr. Ira Kovel KPMG Community Giving Campaign The Kraft Family Mr. William Kramer Mr. Joseph Krasovec Mr. and Mrs. Alan J. Krauss Mr. and Mrs. Lawrence Krulik Mr. Richard E. Kubanik Ms. Alice C. Kuechler Mr. Josh Kulberg Mr. and Mrs. Tomislav Kundic Ms. Beth R. Kurlander Kurtz Family Foundation Mr. Eiichiro Kuwana Mrs. Corey Labadorf LABS, Inc. Ms. Carol L. Lace Ms. Michele LaFave Ms. Belinda Lai Mr. Thomas Lamberti Mrs. Margaret Lamoreaux Mr. and Mrs. Stewart Lande The Laub Family Mr. John Laxmi Mr. Wesley R. Leach The Learman Family Dr. Irwin J. Lebish Legend Shotokan Karate LLC Lehigh Valley Health Network Mr. and Mrs. Alan Leifer and Family Leonard Park Wines & Spirits, LLC Mr. Ronald L. Lerman Mr. and Mrs. Scott Lerner Dr. Philip Lesorgen Level 3 Communications Mr. and Mrs. David Levien Mr. Steven A. Levine Levine Sullivan Koch & Schulz LLP Mr. Benjamin Levy Ms. Ellen F. Levy Mrs. Lenore S. Lewis and Family LFP Broadcasting, LLC Mr. A. Mitti Liebersohn Lightower Fiber Networks Mrs. Maria Lima Ms. Megan Lineberger

LinkedIn Matching Gifts Program Ms. Luciana Lino Mr. Aaron Linsky Mr. Thomas Lint Mr. David Liola Michael and Chris Llewellyn Paul and Elizabeth Loosmann Mr. Steven Loranger Ms. Jennifer Lorenzen Mr. Stuart H. Lubow Barry and Deborah Lucas Lucky's Real Tomatoes Mr. James MacGregor Ms. Betsy Mackey Ms. Cynthia MacKinnon Macy's and Bloomingdale’s Foundation Mr. and Mrs. Richard D. Mager The Magno Family Mr. Brian K. Maier Mrs. Jane A. Malison Mancini Duffy Mr. David J. Maniaci Mr. and Mrs. Martin J. Mannion Ms. Patricia Marcus Curtis Mr. Jeffrey Marcus Michael, Robyn, Annie and Abby Marcus Ms. Noreen Marcus Mr. Robert Marcus Mr. Steven Marentis Dr. Gabrielle Marshall-Salomon Mr. and Mrs. Daniel Marszalek Mr. Bill Matthews Max B. Cohn Family Foundation Mayfair Power Systems, Inc. Mr. Joseph D. Mayo III Mr. Joseph Mazzone Mr. Keenan McBride Mr. Kevin McCarthy Mrs. Mary E. McGinn and Family Mr. and Mrs. Thomas E. McGrath Ms. Katie McIntosh Mr. and Mrs. Edward E. McIntyre Mr. and Mrs. Michael McKeever McKenney's, Inc. Ms. Shirley J. McRae

University of Michigan

Ben Asen

Dr. Ellen J. Dutta EARS To You - Disney VoluntEARS Community Fund East Penn Manufacturing Co., Inc. Ms. Elaine Eaton Mrs. Donna E. Edwards Efficient Combustion & Cooling Corporation Ms. Meridith Egyes Roger and Sondra Eichel Mr. and Mrs. Bob Eisele Mr. Lewis M. Eisenberg Mr. Robert Eisman Mr. Martin Elias Elizabeth and Oliver Stanton Foundation Mrs. Daryl Elliott Mr. Fred K. Ellis Elmwood Charity Fund, Inc. Mr. Curtis A. Elsbernd Empire National Bank Empire Properties Management, LLC Ennead Architects LLP Ms. Joyce E. Erony Ms. Nancy J. Eschedor Estate of Jeffrey Newman

ANNUAL REPORT • 29


Joseph Kellard

Ms. Melissa R. Mirabile Mrs. Millie A. Mitchell Mr. William Mitchell MLB Network Mr. and Mrs. John H. Moehling Mrs. Michelle Monte Mr. and Mrs. Michael Monteleone Ms. Karen Moore Mr. Thomas Moore Ms. Brooke Morgan Mr. Scott Morgan Morgan Stanley Smith Barney Foundation Morgan Stanley Foundation - Employee Giving Program Mori Lee Ms. Linda Joy Morris Mrs. Linda Moslow Mrs. Anita E. Motkowski 30 • THE LUSTGARTEN FOUNDATION

Muchnick Family Foundation Matthew and Louise Mueller Dr. Nancy Mueller Ms. Jane Muhrcke Mrs. Yvette Mulderry Mr. George Mullen and Family Mulligan Security Corporation Mrs. Mary M. Mulvihill Ms. Lynn Murcott Murphy & Fahy Construction Co., Inc. Ms. Ann L. Murphy Mrs. Ellen Murphy Music Choice Muzio Family Foundation Ms. Deborah Nadel Ms. Lauren Naru National Penn Bancshares, Inc. Mr. William C. Neal Netrovert Software Inc. Newell Rubbermaid Jessica and Michael Newshel Mr. Roy Niederhoffer Mrs. Elin Nierenberg Ms. Pamela Noble Mr. David Nochimson Ms. Sue Norris North American Wireless Solutions of NY LLC Northwell Health Mr. Donald R. Novicky Sr. Nutcracker Technology Mr. William G. O'Callaghan Dr. Allyson J. Ocean Och-Ziff Capital Management Matching Gifts Program Mr. and Mrs. James O'Connor Peter and Debra O'Connor Ms. Sarah Oey Offshore Sailing School Mr. Melvin N. Oftedahl Mr. Lionel Ohayon Mr. Christopher L. Oleaga Ms. Deborah J. Olita Omnicom Management, Inc. Mr. Steven Orbuch Mr. Patrick Ortman Mr. Michael L. O'Shea Sr. Outdoor Channel Ms. Jacqueline Page Mrs. Marilyn J. Palmer Panas Volleyball Booster Club Paramus Associates, LP Mrs. Anna Paret Mr. Sherin Parikh Mr. and Mrs. Gregory Park Mr. Scott Parker Participant Channel, Inc. Mr. Hal Parton Pastime Athletic & Social Club, Inc. Mr. Bill Patellos Ms. Linda Lee Paulsen Dr. Judy I. Pawlusiow PCI Group Inc. Mr. Morris B. Pearl

Mrs. Marci Pere Ms. Roslyn Persky Mr. John Pessolano Mr. Adam Peterson Mrs. Maureen Peterson Mr. Andrew Petitti Mrs. Beatrice Peyser Pfizer Foundation Matching Gifts Program PHH Corporation Phil & Anita Gauer Mr. Tony Pianese Ms. Victoria Pierce Mr. Michael Komichak and Ms. Daria A. Pishko Komichak Pj Callahan Foundation, Inc. Playboy Plus Mr. Les Poinelli Mr. and Mrs. Michael Pomeranc Mr. Andy Pon Ms. Julia Pon Mr. Marc S. Porter Mr. Kirk Pothos Ms. Mary Frances Potts Mr. Louis G. Poulin Mr. Andrew Poulos Sr. Powerhouse Paving Mrs. Kirstin Powers Mr. and Mrs. Mark J. Prak Irwin and Audra Press Ms. Lynn Pressler Mr. and Mrs. Barry Prevor Mr. Steven Price Mr. and Mrs. Gary L. Prior Pro Tools Dr. and Mrs. Angelo J. Procaccino Project One, Inc. Pronto Pizza and Pasta Mrs. Gail Propp Mrs. Lynn Przydrozny Pullman & Comley, LLC Pure Play Broadcasting Mrs. Ruth Queen Mr. William Quigley Mr. and Mrs. David J. Rabinowitz and Family Radiant Logic Mr. and Mrs. Richard Radutzky Mr. Milton Ragusa Dr. Veena Rai Raising Hope for Others Mrs. Staci Ramachandran Dr. Louise Ramm Mr. Harvey Rappaport Mr. and Mrs. Steven Rathgaber Mr. Bob Razem Mr. and Mrs. Steve Realbuto Ms. Portia T. Redfield Dr. Lauren Redler ReelzChannel Mr. and Mrs. Timothy Reis Garrett Reisman Mr. and Mrs. Carl and Anna Reisner Mrs. Stacey Remnitz and Family

Photo courtesy of Tara Shanes-Hernandez

Ms. Ellen L. Meckler Mrs. Josephine A. Meilan Lt. General (Ret.) and Mrs. David F. Melcher Mr. and Mrs. Stephen G. Melidones Mercer Ms. Elaine Merians Mr. Tom Messner Metaswitch Networks MetLife Metropolitan Local Masters Swimming Committee, Inc. Metta Fund Mr. and Mrs. Ed Meyer Jr. Michael J. Zamkow and Sue E. Berman Charitable Foundation Philip and Jean Michael Dr. Eugene A. Mickey Mickey's Montauk Mowing, Inc. Mid-Island Y JCC Midlothian Optometric Center Mr. John A. Miers Milken Family Foundation Millennium, The Takeda Oncology Company Matching Gifts Mrs. Eliza Miller Mr. Marc Miller Mr. Timothy Miller Minerals Technologies

Ms. Meaghan A. Repko Rex and Nelle Jackson Foundation Ms. Carol A. Rhoads Ms. Julie Riccomini Mr. and Mrs. Edward F. Rieger Ms. Margaret R. Riemer Mr. Thomas Rikert Ms. Rachel S. Ringler Mr. George A. Rippey and Ms. Linda Paulsen Ritchey Family Foundation, Inc. Riverdale Country School Mrs. Mary Rizzo Robert Graham Designs LLC Robert R. McCormick Foundation Mr. Nicholas Robinson Ms. Roberta Robinson Ms. Melissa L. Roeters Mr. and Mrs. Steve Rogness and Family Mr. Gerald Rokoff Mrs. Dana Romanello-Flynn Ms. Lorraine E. Rooney Ms. Andrea Rosenberg Ms. Lauren Rosenberg-Moffitt Mr. Moe Rosenblum Mr. Andrew B. Rosengard Mrs. Marian Rosenwasser-Jordan Mr. and Mrs. Steven Rosenzweig Mr. Michael Ross Mr. and Mrs. Raymond W. Ross Rotary Club of Lexington Mr. and Mrs. Clarence Roth III Rovi Corporation Mr. Andrew Rowley Roy J. Zuckerberg Family Foundation Mr. and Mrs. Barry Rubenstein Ms. Jami Rubin Mr. Kit Rudd Ruskin Moscou Faltischek, P.C. Mrs. Barbara Russell Ms. Jeanne Y. Russell Mr. Alex T. Russo Ms. Anna M. Ryan Mr. Peter Ryan Safety Tire Seal Salesforce.com Foundation Matching Gifts Ms. Hara Salkovitz Ms. Penny Sallinger

Mr. and Mrs. Marc Samit Mr. Bradley Samuels Sandpiper Fund, Inc. Sandra's Comfort, Inc. Mr. and Mrs. Roger W. Sant Mr. Thomas Santiago Mr. and Mrs. Kurt W. Saraceno Saratoga Race Course Trainers’ Event Ms. Mary T. Sargent Mr. Robert and Anne Sargent Mr. and Mrs. Andrew J. Sarno Ms. Teresa A. Sarno Mr. Mark Satov Jason and Mindy Satsky Mr. Lance Sauerteig and Ms. Wendy Kavasin Mr. John F. Sawyer Saxon Associates Mr. Stuart Schechter and Ms. Jaeyeon Jung Ms. Linda Schector Schlachtenhaufen Family Mrs. Donna Schlonski Mrs. Lisa Schlonski and Family Mr. John Schmidt Mr. Donald Schneider Mr. Kenneth M. Schneider Ms. Lillian Schneider Mrs. Tami Schneider Mr. and Mrs. Michael Schock Mr. and Mrs. Brian Schorr Mrs. Carmen P. Schramm and Family Schulman Family Foundation Mr. Harvey Schulweis and Ms. Barbara Benerofe Schulze & Burch Biscuit Co. Mrs. Nancy Schuman Mr. Robert B. Schumer Ms. J. Virginia Schurz Mr. Peter Schwalbe Mr. William Schwalbe Mr. Jerome M. Schwartzman Scottrade Seaboard Forwarding Co., Inc. Ms. Katherine A. Sears Mr. Bruce Seger Ms. P.W. Seitz Sertex Servcorp. Mr. Scott Shane Mr. and Mrs. Joel Shatles Ms. Dawn Shell Shell Point Retirement Community Dr. Malini Shenava Mr. Sunil Shenoi Dr. Vasudeva Shenoi Mr. Jonathan M. Sherman Ms. Lorraine Shields Dr. Robert D. Shlien Mr. Joseph Shreiner Ms. Martha Lovenheim Siegel Mr. and Mrs. Joel Sieger Siemens Caring Hands Foundation Ms. Doreen M. Sigelko

Mr. Robert Silver Ms. Regina L. Silverman Dr. and Mrs. Douglas Simon Dr. Karen Singer Mrs. Linda Singer Mr. Jeffrey S. Sites Ms. Jennifer Sklar-Romano Mr. David R. Sklaver Dr. and Mrs. Jim Slater Reverend William T. Slater Mr. Ronald Slevin Mr. Bill D. Smith Mr. and Mrs. Brian Smith Mr. Declan Smith Mr. and Mrs. George Smith Mrs. Holly Smith Mrs. Ruth A. Smith Mr. Chuck Smith-Dewey Smithfield Foods, Inc. Mr. Bruce Smylie Mrs. Katherine Sobel Mr. and Mrs. Joseph Sondej Jr. Ms. Carol A. Sonnessa Sonzogni, Bottitto & Fingerhut LLC Soros Fund Charitable Foundation Matching Gifts Program Dr. and Mrs. Jack Soterakis Mr. and Mrs. Ari Spar Mr. Walter F. Spardel Dr. Howard Spector Ms. Anne Spitza Mr. and Mrs. David Spring and Family St. John Fisher College St. Peter's Lutheran Church Mrs. Carol Stanzione Ms. Karen Staub Mr. Jim Steber Mr. Carl Steen Mrs. Marcia Steinberg Stellar Solutions Foundation Mr. Robert Stellato and Ms. Debra Scordino Stephen and Shelly Verber Fund Stephen J. Meoli Memorial Foundation Mrs. Ruth B. Stern Steven and Beverly Rubenstein Charitable Foundation, Inc. Mr. Frank Stiebel Ms. Stephanie J. Stiefel Mr. and Mrs. Stephen Stier Mrs. Elizabeth Straight Ms. Heidi E. Strom Suffolk Games Enterprises, Inc. Mr. Scott R. Sulzberger and Family Mrs. Barbara Surdej Mr. and Mrs. Len Susman Mrs. Judy Taboada Mr. and Mrs. Ross H. Taff Talonvest Capital, Inc. Ms. Taryn B. Tanzer Ms. Linda S. Tardiff Mrs. Mary M. Tassini Mr. William J. Taylor and Ms. Vessie Ware Mr. Larry Tchou ANNUAL REPORT • 31


Salk Institute for Biological Studies

The Woodmere Club Charitable Foundation The Wool Family Foundation Theatrical Protective Union Mr. Francis Thompson II Mr. Peter Thonis 32 • THE LUSTGARTEN FOUNDATION

Tiffany & Co. Mrs. Tammy Tlachac Mr. and Mrs. Robert B. Tober Mrs. Gail Tomberg Tommy Scogs Foundation, Inc. TOPA Diagnostics Towers Watson Mr. Scott R. Treiber Mr. William G. Trillo Trinity United Methodist Women Trippe Lite Manufacturing Co. Mr. Richard B. Turan and Family Turner Construction Company TV One TZP Cares Foundation Alan and Robyn Udell Mr. and Mrs. Arthur Udell Mr. and Mrs. Mitchell Udell United Way of Benton & Franklin Counties United Way of Bergen County University Physicians, Inc. Mrs. Elaine Unterman Valero Texas Open Mr. and Mrs. William Van Winkle Mr. Billy W. M. Vanadia Ms. Lisa M. Vandetti Mr. George T. Varones Mr. Anthony J. Vela Mr. Vincent Vellucci Alexis and Lou Ventre Mr. George L. Venuto Verizon Foundation Mr. Stanley Vinton Mrs. Chris Viola-Weiss Mr. John Vissicchio Mr. Domenick Vita Vivid Entertainment LLC Mrs. Kathleen C. Voigt Mrs. Erica Vozzolo Vubiquity Mrs. Irene T. Wachter Ms. Edith H. Wah Mr. Joseph Wald Mr. and Mrs. Christian Wall Mr. and Mrs. Damian E. Wall Mr. John Wallace Mr. Todd Walsh Mrs. Judi Walters Mr. Wolfgang Wander Mrs. Elizabeth Ward Mr. Bruce Washburn and Ms. Joan McCabe Wasserman Family Foundation Mrs. Becky S. Watson Waveguide, Inc. Mr. Daniel Wechter Mrs. Alice Weed Weinshel Goldfarb Foundation, Inc. Mr. Colin Weir Mr. Jeffrey Weiss Ms. Joelle C. Weiss Mr. and Mrs. Scott Weiss Wellfleet Foundation, Inc.

Community Events (events raising at least $1,000)

Mrs. JoAnn Welter Mr. Todd A. Wendling Westlake Village Inn Mr. Michael J. Whalen Mr. Kevin P. Wheeler White Plains Hospital Center Dr. David Whitlock Dr. Mark Wilkinson Ms. Nanci Wilkinson Mr. Robert Willens Drs. Derek and Valerie Williams

Athletics

Ben Asen

Teach A Man To Fish Foundation Telco Access Partners LLC Mr. Frank P. Terzo Mrs. Rachel Teslenko Test Force Corporation The Anbinder Family Foundation The Anikstein Family Foundation, Inc. The Bowling Family Foundation The Buller Foundation The Carl Marks Foundation, Inc. The Custard Hut The Darrel & Audrey Weber Foundation The David and Lucile Packard Foundation Matching Gift Program The Dunphy Family Fund The Grimaldi Foundation The Hagani Foundation, Inc. The Hanna Charitable Fund The Heiser Family Fund The Hollander Foundation The Irwin & Daryl Simon Foundation The Lawrence Schacht Memorial Fund The Martin Agency The McKeever Family Charitable Fund The Oatley Team The Plaut Family The Phelan Foundation The Prudential Foundation Matching Gifts Program The Ray Family Charitable Gift Fund The Ruth & Louis Gerstle Foundation, Inc. The Shaheen Family Fund The Swell Dudes The Vincent Dowling Family Foundation Inc. The Weather Channel The Weinreb-Berenda-Carter Foundation Inc. The West Family Foundation The William & Phyllis Mack Family Foundation, Inc.

Mr. Gregg Willinger Mr. Bradford Wilsted Mr. Fred Wistow Mr. Steven Witt Wolf, Rifkin, Shapiro, Schulman & Rabkin, LLP Mr. Raymond Wood Mrs. Janet Wortman Mr. and Mrs. Peter A. Wright Mrs. Connie Wuestenhagen Lt. Col. Barbara Wunderlich Ms. Carole Yaley Corso Mrs. Patricia M. Yarbrough Mrs. Adrienne Yarnold Mr. Randy Zablo Mr. Edward Zadigan Mrs. Jennifer Ziegler and Family Ms. Shari Zimmerman

Beginning in 2016, our annual report will only list contributions that total $2,500 or more. This list of donors has been prepared with the greatest of care. We sincerely regret any errors or omissions. If you have questions about this list, please contact The Lustgarten Foundation at 516.803.2304.

Bedford High School Volley for the Cure Canter for the Cure in Memory of Arlene Bates Toyne Charity Ride at Flywheel Columbia Trail Tromp Memorial for Bill Harrington Sr. Fundraiser in Memory of Claire Rose Bavaria Haymakers for Hope Inc. Fundraiser in Honor of Jack Brill Hoops for a Cure Iowa Classic/Janesville Cedar River Riders Jazzercise Group of Upper Arlington Charity Event Jenn’s Countryside Ride for Cancer/Motorcycle Ride Kodiak Swim Fundraiser in Honor of Carl Smith Legend Shotokan Karate Fundraiser Maryland Men’s Lacrosse Purple Out Massapequa High School Basketball “Alumni Game” Charity Fundraiser Miles 4 Michelle Pure Barre Chicago River North – Pure Give Class Purple Pucks for Pancreatic Cancer Research Score for the Cure Shooting for a Cure for Pancreatic Cancer Steve Koziol Memorial Salmon Derby Strike Out Pancreatic Cancer Team Dream Swim Tour De Pour Village Cup Regatta Wiffle Ball Tournament in Honor of Steve Brosky Jr.

Endurance Events 2015 New York City Half Marathon: Sandra Duffy, Linda Gennusa and William Nugent Atlanta Track Club’s Thanksgiving Half Marathon in Honor of Rick Sforzini BJ Walks America Ironman Lake Placid Ultra Triathlon - David Swezey Love of Bill Tour Malibu Triathlon - Lindsay Malison Newbegin Race the Lake Half Marathon RJA Memorial Mighty Montauk Triathlon

Golf Outings AC DC Golf Tournament AOH Division2 Golf Outing in Honor and Memory of Msgr. Jim Kissane ASIS Long Island Golf Outing Bill Tamburro Jr. Golf Tournament Brett Rollman Memorial Golf Outing Bretton Woods Golf Club in Memory of Tony Silkorski Brian McGovern Memorial Golf Tournament Carol B. Smith Memorial Golf Tournament Carol Van Auken Golf Outing Chubb Charity Challenge Colin Wardle Memorial Golf Tournament Croatian American Charitable Foundation Golf Outing in Memory of Val Blaskovic Debbie Open Golf Outing Eddie Ivanoski Memorial Golf Tournament Golf Outing in Honor of Jeff Pirozzi Hit and Run Golf Outing Hoopalator Open Golf Tournament Howard Shapiro Golf Outing

Jack Haley Golf Tournament Jeffrey K. Elder Memorial Golf Tournament JFK Air Cargo Golf Outing Jim Alberto Memorial Golf Classic John V. Duffy Memorial Golf Outing Laurie Milotte Golf Tournament Loren Findorak Pancreatic Cancer Golf Outing No One Fights Alone Memorial Golf Outing Old Oaks Charity Weekend Rensselaer Honda’s Tom Gorman Memorial Golf Outing Rock Hill Golf and Country Club 50th Anniversary Party Scramble for Shelly Steve Hatje Golf Outing Swing Fore Hope Terry Hagen Memorial Golf Tournament The Gene Toth Memorial Golf Tournament The Knicker Open at Medinah Country Club The Larry Golf Classic The Lustgarten Foundation Golf Outing

Milestone Celebrations In Memory of Keith Malison In Memory of Sydney Lustgarten In Memory of Vincent Peter Magro In Memory of Walter T. Bohorquez Jerry’s Pals - Amy’s Bat Mitzvah Project Mindy and Marc’s Wedding Peter “Steve” MacDonald Fundraiser Sarah Curtis’ Bat Mitzvah Fundraiser Wedding Donations in Memory of Laura Lyn Inglis Andie Novenstein’s Bat Mitzvah Project in Memory of Philip Scheier Celebration of Life in Memory of Carl Silvestrone George Wong Memorial Fund in Memory of Mary Greta Ladiana

Social Events A Cure for Commie Americana Manhasset Champions for Charity Barb Reuteman Bags Tournament for Pancreatic Cancer Ben Diamond Bake Sale Big Daddy’s Poker Tournament Bracelets for Dave Gurley Bring a Buck in Honor of Ronald R. Holman Cars vs. Cancer Car Show Cellini Lodge #2206 Charitable Foundation Pasta Night Cheers to a Cure Chop and Stout Month at Shoreline Brewery Circle of Hope Custer’s Cruise In EyeKrafters Medical Optics Grand Opening Frenz for a Cause Masquerade Extravaganza Ga May - in Memory of Mark Kuller Go With Courage Immaculate Heart Academy Knitting Club International Tabletop Day for Pancreatic Cancer Research Jason Paver Fundraiser Jewelry Trunk Show in Memory of Louis Fortunoff Leonard Park Wines and Spirits Event in Honor of Joseph Larizza Let’s Help Find a Cure in Memory of Lou DeSciloi

LinkedIn Fundraiser Long Island Craft Beer Week Luau for Pancreatic Cancer Research Mid Atlantic Chili Heads Mo-Hawk Less Cancer Motorcycle Benefit Ride and Jam Murder Mystery Fundraiser Nancy Wernikoff’s Tea in Memory of Serge Neuron Mirror Books Night Out for A Cure No Shave November Pancakes for a Purpose in Memory of David A. Anstadt and John Bradley Pastime Athletic and Social Club Inc. Lobster Bake Pat’s Place Fundraiser in Memory of Ralph Bruschini Punch Out Pancreatic Cancer Purple Pumpkins for Pancreatic Cancer Awareness and Search for A Cure in Memory of Joseph T. Alessi and George Solomos Race 4 A Cure Raising Hope for Others in Memory of Kathleen Loomis Riverdale Country School Road Knight Auto Club Annual Car Show Sandra’s Comfort Raddle the Bottom Bluegrass & Folk Festival Southeast Foraging Dinner St. Fisher College Pie in the Face Fundraiser St. Peter’s Lutheran Church Annual Harvest Festival Steve’s Happy Hour Susiepalooza The Ambrosio & Bellotti Charitable Foundation, Inc. Fundraiser The Rook Pub Bartending for Charity Tribe Body Presents a SPOOK-TACULAR Event

Walks & Runs 5cacia Run for Pancreatic Cancer at Ohio University 5K Beer Run/Walk in Memory of Beth Moore and Thomas Lesselyong Andrea’s Adventure Presents: Hope Heart and Sole Bob Kochka Memorial 5K Run/Walk Chuck Jenkins Walk/Run Crush Pancreatic Cancer 5K/Chillin’ for Chili Cook-Off Gloria Prodoehl and Diana Agozzino Memorial Run/Walk Hope Begins with Me Howie Levy Cross Country Ski Family Fun Run Julia’s Run for Pancreatic Cancer Research Lake Geneva Walk for Sandy Making Every Mile Count in Memory of Helene Miller Pound the Pavement for Purple 5K Run/Walk Purple Ribbon 5K Run/Walk Rick’s Run Rock and Run 5K Sale Machine Walking Challenge Schulze & Burch Biscuit Co./Tripp-Lite Race Walk Championships Sherry Shumaker Memorial Pancreatic Cancer 5K Run/Walk Snohomish River Run The Michael Abelon Walk

Workplace Programs BTIG Charity Day in Honor of Harriet Plank DreamLine Partners and Employees


1111 Stewart Avenue Bethpage, New York 11714 Phone: 1-866-789-1000 www.lustgarten.org

Profile for Lustgarten Foundation

Annual report 2015  

Annual report 2015